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Executive summary 
 
This report provides a methodological guidance on cost-effectiveness analysis in the view 
of future evaluations of the EU interventions currently funded under the Common 
Financial Framework of the food chain area (CFF, Regulation (EU) No 652/2014). The 
report was commissioned by DG SANTE. 
Under the CFF, the EU is either funding or co-funding eligible costs faced by Member 
States when implementing phytosanitary and veterinary programmes, official control 
activities, and veterinary and phytosanitary emergency measures. These interventions 
aim at contributing to a high level of health for humans, animals and plants along the 
food chain, by preventing and eradicating diseases and pests and by ensuring a high 
level of protection for consumers and the environment, while enhancing the 
competitiveness of the Union food and feed industry. 
This report presents a methodology on how to address relevant policy questions such as: 
“Should more funding be awarded to prevention measures or to control measures to 
reduce the risk of outbreaks of classical swine fever in pigs?” or “is the introduction of 
new e-learning tools for official staff more effective in increasing the quality of the official 
controls compared to workshops?” This report provides evaluation methods to answer 
this type of questions and illustrates the methodology introduced for specific CFF related 
policy questions. These methods are based on disaggregated data and regression 
techniques.  
Economic evaluation is a systematic analysis tool to assess and quantify whether the 
interventions produce the expected effects, and to help draw conclusions on the cost-
effectiveness of the different EU funded programmes. Thus, economic evaluation is a 
funding allocation tool that allows decision makers with a budget constraint to make 
informed choices on which interventions to allocate funding to. 
When performing economic evaluation, three main challenges need to be addressed; (i) 
how to measure the costs, (ii) how to quantify the effects, and (iii) how to identify the 
causal impact of the intervention under evaluation. 
Measuring the costs 
The costs to include in the evaluation depend first on the perspective chosen as the cost-
effectiveness result can be different from the view point of the Member States, the 
European Commission, or the European citizens. In the broader point of view - the 
societal perspective- the evaluation would need to account for the costs for the EU but 
also the costs for the Member States, and the producers and consumers along the food 
chain.  
When the scope of the economic evaluation includes different regions of different 
Member States, and the evaluation period spans over more than a year, methods that 
ensure comparable costs across Member States and over time, need to be applied. 
Measuring the effectiveness 
Three types of effectiveness indicators can be used in the evaluation: (i) output 
indicators and (ii) result indicators that measure the outcomes that are directly related 
to the interventions; (iii) impact indicators, which are relevant indirect economic and/or 
social outcomes induced by the interventions. Which indicators to use depends mainly on 
the policy question or the type of intervention to evaluate, and the stage of the policy 
cycle that needs to be evaluated: before, during or after the implementation of the 
intervention. 
A methodology to develop a set of indicators to evaluate the different levels of 
intervention in the spending areas covered by the CFF is suggested. The proposed 
indicators update and complement the existing set of 21 technical indicators currently 
used by DG SANTE.  
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The collection of these indicators for monitoring or evaluation purposes requires also the 
collection of data on contextual indicators that frame the environment in which 
interventions are implemented. 
Identifying the causal impact of the intervention 
The main challenge of identifying the causal impact of an intervention is to be able to 
measure what would have happen in the absence of the intervention under evaluation. 
This counterfactual situation is by definition not observable as regions or Member States 
are either receiving EU funding or not. The aim of public policy evaluation methods (or 
counterfactual impact evaluation methods) is then to find the best proxy possible to 
approximate the counterfactual situation, i.e. to find a so-called “control group”. The 
report discusses possible control groups. 
Measuring cost-effectiveness in the food chain area 
Possible ways of defining control groups are suggested in the context of the 
interventions funded in the food chain area. Given the nature of the policy process that 
defines the working programmes for the spending in animal and plant health, and that 
aims at a proper identification of the risks for subsequent awarding of funding, it can be 
assumed that the entire target population receives EU funding. In this case, when the 
entire target population receives the intervention, the causal impact of an increase in 
funding over time or a change in the intervention can be identified.  
To perform a cost effectiveness analysis regression methods are suggested to evaluate 
the impact of EU funding. In particular, the Net benefit of a change (new intervention, 
extended intervention, additional measures within the existing intervention) in the 
intervention can be computed accounting for contextual indicators using appropriate 
techniques to solve a potential selection bias. 
A list of selected cost-effectiveness indicators (CEI) is proposed for each intervention in 
the three spending areas i.e. Plant Health, Animal Health, and Official Controls. The 
feature of these selected CEIs is that they can be computed at different level of 
aggregation (local areas, regions, MS, by disease or types of disease, for a whole 
programme, etc.). 
Implementation requirements 
The methodology described in this report is an in-depth-data-driven technique. This 
technique is grounded on real data and provides robust ex-post evidence on the impact 
and the efficiency of interventions. This method then requires careful planning of the 
monitoring and evaluation of the interventions, in particular on data requirements. 
The implementation of this method requires the collection of disaggregated data (e.g. at 
the level of regions, farmers, laboratories etc.) to compute the effectiveness indicators, 
the costs, and the contextual indicators. 
Valuable sources of data are already available and these are related to the costs, 
diseases status, implementation of the interventions, farmers and trade and other 
economic outputs that need to be consolidated to perform a cost-effectiveness analysis. 
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1 Introduction 
1.1 Aim of this guidance 
 
The aim of this report is to provide a guideline on the monitoring and evaluation of the 
activities currently funded under the Common Financial Framework for the food chain 
area (CFF, Regulation (EU) No 652/2014). 
 
More specifically this report shall: 
• Propose a methodology to evaluate the impact of the interventions funded under 
this CFF. 
• Present methods to measure whether the effectiveness of these interventions is 
worth the costs and discusses their advantages and their limits. 
• Serve as guidance to support policy makers in the upcoming preparatory work for 
the proposal for a post-2020 food chain programme, planned to start in the 
second half of 2017. 
• Provide policy makers with the evaluation tools to perform a first cost-
effectiveness analysis (CEA) in view of the CFF ex-post evaluation, to be carried 
out by June 2022 (Article 42 of Regulation (EU) No 652/2014). 
 
1.2 Outline of the report 
 
The report is organised as follows; the remainder of Chapter 1 provides an overview of 
the type of interventions and the framework logic of the CFF for the food chain area. The 
concepts of monitoring, economic evaluation and cost-effectiveness analysis (CEA) are 
also introduced.  
When performing economic evaluation, three main challenges need to be addressed; (i) 
how to measure the costs, (ii) how to quantify the effects, and (iii) how to identify the 
causal impact of the intervention under evaluation. 
Chapter 2 focuses on the costs and describes what type of costs should be considered in 
the evaluation and how to measure them.  
Chapter 3 defines indicators to measure effectiveness. The current list of indicators 
covering all CFF spending areas is reviewed and new indicators are proposed, in view of 
future economic evaluation.  
The challenges of causal analysis in non-experimental settings are tackled in Chapter 4. 
The necessity to account for contextual indicators and potential selection bias is 
explained. Counterfactual Impact Evaluation (CIE) and the concept of counterfactual in 
public policy evaluation methods are introduced. 
Chapter 5 describes how to measure cost-effectiveness for the interventions funded in 
the food chain area. Possible identification strategies are discussed based on the design 
of the interventions. The Incremental Cost-Effectiveness Ratio (ICER) and how to 
measure it with econometric based techniques is presented. The use of the Net Benefit 
to measure the Incremental Cost Effectiveness Ratio (ICER) for different Willingness to 
Pay (WTP) is also introduced. Finally based on the indicators presented in Chapter 3, a 
list of Cost-Effectiveness Indicators for each intervention funded under the CFF is 
proposed. 
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Chapter 6 tackles the prerequisites for implementing the methodology, the evaluation 
plan and the data requirements. Examples of studies are proposed in Chapter 7.  
The results of a literature review on food crisis, animal diseases and plant pests are 
reported in Annex 1. The focus of the review is on the costs of plant pests and animal 
diseases outbreaks in Europe, North America and Australia for the period of 1997-2017. 
Figure 1 – Overview of the report 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: CIE= Counterfactual Impact Evaluation, ICER= Incremental Cost-Effectiveness Ratio, WTP= 
Willingness to Pay, ∆E=variation in effect, ∆C=variation in cost. 
1.3 Overview of the EU interventions funded in the food chain 
area 
 
The general aim of the European Union interventions under EU Regulation No 652/2014 
is to contribute to a high level of health for humans, animals and plants along the food 
chain, by preventing and eradicating diseases and pests, or at least prevent further 
spread into the Union territory, and by ensuring a high level of protection for consumers 
and the environment, while enhancing the competitiveness of the Union food and feed 
industry. The ceiling for EU funding is almost 1.9 billion EUR for the current seven year 
financial period (MFF 2014-2020) in these interventions. 
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1.3.1 Types of interventions funded 
 
Animal health 
 
The European Union co-finances specific measures in order to prevent and reduce the 
number of outbreaks of animal diseases and zoonoses, which pose a risk to human and 
animal health. It provides co-funding through the Veterinary programme for 
eradication, control and surveillance and the Emergency measures.  
 
Grants in the Veterinary programmes for eradication, control and surveillance might 
be awarded to Member states (MS) annually or multi annually. The Union sets the list of 
eligible diseases for which funds are granted for national programmes (Annex II to 
Regulation (EU) No 652/2014) and then prioritise them based on the threat they pose to 
human health (zoonosis), the impact on animal livestock production, trade and new 
epidemiological developments (annual/multi-annual work programmes adopted by the 
Commission). This list can be supplemented. 
 
Within the Veterinary programmes the Eradication programme aims to achieve 
biological extinction of an animal disease or zoonosis, while the Control programme 
aims to maintain the prevalence of the disease or zoonosis below a sanitary acceptable 
level. The Surveillance programme collects and record data on specific diseases in 
defined populations to assess the epidemiological evolution and target measures for 
control and eradication. 
 
The Union co-finances measures including sampling, testing, cost of compensation for 
the market value of slaughtered or culled animals, cost of compensation for the market 
value of destroyed animal products, vaccination, cost of cleaning, disinfection, and 
disinfestation. 
 
Grants for Emergency measures are awarded to countries to control epidemics that 
are likely to constitute threat to the Union due to their significant impact on human or 
animal health and agricultural production. The Union sets the list of eligible diseases 
(Annex I to Regulation (EU) No 652/2014), but might also supplement the list in case of 
a new disease. The eligible costs include the compensation for the market value of 
slaughtered or culled animals, the market value of destroyed products, cost of cleaning, 
disinfection, disinfestation, transport and disposal of carcasses, and destruction of the 
contaminated feeding stuff and vaccination. 
 
Plant health 
 
The European Union co-finances specific measures in order to protect plants and plant 
products from harmful pests (harmful organism, HO) which can have devastating effects 
on EU agriculture, environment and economy. It provides co-funding through the 
national Survey programme concerning the presence of pests and the Emergency 
measures.  
 
Grants might be awarded to MS for annual or multiannual Survey programmes that 
survey the presence of pests in accordance with a predefined list and pests not included 
in the list that represent imminent danger to the Union. The programme co-finances 
measures including visual examination, sampling, testing and trapping. 
 
Emergency funding is awarded to countries to eradicate pests from an infested area, 
or if this is no longer feasible, at least contain their presence and to prevent their further 
spread into the Union territory. Funding might be award to MS neighbouring countries 
with the presence of pests to prevent the entry of the pest to Union territory. The 
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programme co-finances the market value of destroyed plants and plant products (since 
January 2017), cost of treatment, destruction, removal, cleaning, and disinfection. 
 
Official controls 
 
The EU official controls ensure the enforcement of regulatory requirements, and that the 
EU MS authorities carry out the existing rules in order to maintain the safety of humans, 
animals and plants along the food chain. The two main activities funded include the EU 
Reference Laboratories (EURLs) and the Better Training for Safer Food initiative. 
 
The EURLs aim to guarantee uniform testing in the MSs and take part in the risk 
assessment in the area of laboratory analysis to ensure compliance with the EU food 
chain regulatory rules. Their tasks include providing National Reference Laboratories 
(NRLs) with analytical methods and diagnostic techniques, training NRL staff and experts 
from developing countries, assisting the Commission scientifically and technically, 
collaborating with the competent laboratories in non-EU countries and assisting actively 
in the diagnosis of animal disease outbreaks in MS.  
 
The Better Training for Safer Food trains MS and candidate country national authority 
staff involved in official controls in areas of food and feed law, animal health, and plant 
health. The trainings are designed to keep authority staff up-to-date with the EU law and 
ensure controls are carried out in a uniform, objective and efficient manner in all MS. 
Trainings are open to third country participants also, especially to developing country 
participants to ensure they are familiar with EU import requirements and EU funding. 
 
1.3.2 Financial framework regulation 
 
The CFF for the food chain area defines eligible costs, the timeline for application, and 
the list of diseases for which each MS (and neighbouring third countries) can submit an 
application. 
 
Eligible costs 
 
For animal and plant health interventions the basic co-financing rate is 50% of the 
eligible costs. The rate can be increased to 75% in case of cross-border activities 
implemented together by two or more MS or for MS whose gross national income per 
capita is less than 90% of the Union average. Furthermore, the rate might be increased 
to 100% for measures designed to avoid human casualties or major economic 
disruptions in case of serious human, plant and animal risk for the Union. The rate might 
be also increased to 100% in case the interventions are implemented in third countries. 
 
The Commission provides 100% funding for EURLs activities as well as for the Better 
Training for Safer Food trainings. 
 
Timeline for grant application 
 
The timeline for animal and plant health programmes is the following. MSs shall submit 
by 31 May their national programmes applications, which are due to start in the 
following year. The national programme description must contain information about the 
epidemiological situation of the disease; the description of the geographical area where 
the programme is to be applied, the duration of the programme, the measures, the 
estimated budget, the targets, and the indicators to measure the achievements. The 
Commission evaluates the applications, addresses additional questions to the MSs, 
modifies and adapts the list of programmes, measures and amount and by the 31 
January notifies MSs about the grant decisions. MSs submit the interim report by the end 
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of August and the final reports and payment requests by the end of April of the following 
year. The Commission reimburses the eligible co-financing payments at the end of July. 
 
The timeline for animal health emergency funding is the following. Within one month 
after confirmation of the occurrence of outbreak the MS requests financial support from 
the Commission, and provides information on the ongoing and planned actions. Within 
two months the MS submits a detailed budget plan and co-financing request, then within 
the next two months the Commission notifies the MS about the financing decision. The 
MS submits the detailed payment application 6 months after the eradication was 
completed, then no later than within 3 months the Commission assesses the financing 
request and reimburses the eligible cost. 
 
The timeline for plant health emergency funding is similar, but with extended deadlines. 
Within two months after the outbreak the MS submits its financial request and 
preliminary information, and no later than 6 months the detailed budget plan. Then 
within the next 6 months the Commission evaluates the request and notifies the MS 
about the decision. The final request for payment is submitted within 6 months after the 
eradication or containment of pests and the eligible cost is reimbursed within 3 months. 
 
1.4 What is economic evaluation? 
1.4.1 Difference between monitoring and evaluation  
 
Monitoring is a process of data collection about a programme in order to identify 
implementation problems and to generate information for future evaluations. The data 
collected will reflect changes both due to the EU interventions and also to those that are 
caused by other factors. 
 
While monitoring looks at “what” changes have occurred since the implementation of a 
policy intervention, evaluation looks at “whether” the intervention has had an impact in 
relation to its objectives by examining the results chain (inputs, activities, outputs, 
outcomes and impacts), processes, contextual factors and causality. 
1.4.2 Evaluation criteria 
 
When performing an evaluation of the CFF in the food chain area the responsible 
authorities are required to follow the Better Regulation Toolbox, and hence to use the 
following five main evaluation criteria at each stage of the interventions’ lifecycle: 
effectiveness, efficiency, coherence, relevance, and EU added value. Additional criteria 
can be added to this list.1 
This guidance focuses on the methods to assess the first two criteria: effectiveness and 
efficiency. Economic evaluation looks at the relation between the impact (or the 
effectiveness) generated by the intervention and the cost of the intervention, the two 
cornerstones of efficiency analysis. 
 
 
                                           
1 See Tool #47. Evaluation criteria and questions. https://ec.europa.eu/info/sites/info/files/file_import/better-
regulation-toolbox-47_en_0.pdf 
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1.4.3 What is cost-effectiveness analysis (CEA)? 2 
 
Cost-effectiveness analysis (CEA) assumes that the decision maker seeks to maximize 
achievement of a defined objective by using a given budget. It also assumes that the 
decision of whether an intervention is worthwhile is made using an external standard (a 
budget constraint or threshold cost-effectiveness ratio). (Definition from Drummond, M., 
et al., 1997) 
 
CEA is a type of “full economic evaluation” where both the cost and the impact of 
interventions are examined in a comparative analysis, in opposition to a partial 
evaluation in which only costs (cost evaluation) or only impacts (impact evaluation) are 
compared between interventions. When only the cost-effectiveness of one intervention is 
examined the partial evaluation is called cost-effectiveness description. 
This method of evaluation comes from the health sector which usually makes use of 
experimental settings, where for instance the cost-effectiveness of two types of 
intervention needs to be compared and assessed. Patients are randomly assigned to one 
group receiving one intervention (A) or to another group receiving another intervention 
(B). 
When assessing the cost-effectiveness of the two interventions A and B, the difference in 
cost is then compared with the difference in effect, in an incremental analysis, the 
Incremental Cost-Effectiveness Ratio (ICER).3 
Incremental Cost-Effectiveness Ratio (ICER) = 

		
		

=
∆
∆
 
 
The random assignment of the patients to either intervention B or A ensures that the 
difference in cost and the difference in effect measured by the ICER is only due to the 
difference in interventions (and not for instance because patients receiving intervention 
B have different characteristics such as being older, or having less risk factors than 
patients receiving intervention A). 
The cost-effectiveness plane in Figure 2 displays the four possible cases: in quadrant IV 
intervention B is less effective and more costly than intervention A; in quadrant II, B is 
more effective and less costly than intervention A; in quadrants IV and II, the ICER is 
negative. In quadrant (IV) intervention A dominates as intervention B is less effective 
and more costly. In quadrant (II), it is intervention B that dominates as it is less costly 
and more effective than intervention A. 
The most frequent cases are usually found in quadrant I and quadrant III, in which 
respectively intervention B is more costly and more effective, or less costly but also less 
effective than intervention A. In these cases, the ICER is positive and the public 
authorities would need to assess the cost-effectiveness of intervention B given their 
willingness to pay (WTP) per effective unit and compare it to a ceiling not to be 
exceeded. The region to the right of the dotted line in Figure 1 is the cost-effectiveness 
region determined by the maximum acceptable ICER or willingness to pay (WTP). 
Intervention B is then cost-effective if ICER <WTP equivalently if WTP*∆ − ∆ > 0. 
                                           
2 See Chapter 2 “Basic types of economic evaluation” and Chapter 5 ”Cost-effectiveness analysis” in 
Drummond, M., et al., Methods for the economic evaluation of health care programmes. 2nd edition ed. 
Oxford Medical Publications. 1997, Oxford. 
3 See Chapter 2 “Basic types of economic evaluation” and Chapter 5 ”Cost-effectiveness analysis” in 
Drummond, M., et al., Methods for the economic evaluation of health care programmes. 2nd edition ed. 
Oxford Medical Publications. 1997, Oxford. 
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WTP*∆ − ∆ is the Net Monetary Benefit (NMB) of intervention B, that is the increase in 
effectiveness (∆), multiplied by the amount the decision-maker is willing to pay per unit 
of increased effectiveness (WTP), less the increase in cost (∆)”.4 
CEA mainly differs from other types of economic evaluation in the way the effect of the 
intervention is measured. In CEA, effects are measure in “natural” units compared for 
instance to Cost-Benefit Analysis (CBA) where the effects are quantified in monetary 
value.5 For this reason, CEA is usually used to evaluate health care interventions where 
effects are more difficult to value in monetary terms. 
It is important to stress that WTP is a policy parameter given as a key input to CEA. 
  
                                           
4 See Chapter 5 ”Cost-effectiveness analysis” in Drummond, M., et al., Methods for the economic evaluation of 
health care programmes. 2nd edition ed. Oxford Medical Publications. 1997, Oxford. 
5 See Tool #57. Analytical methods to compare options or assess performance. 
https://ec.europa.eu/info/sites/info/files/file_import/better-regulation-toolbox-57_en_0.pdf 
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Figure 2 - The Cost-Effectiveness Plane 
 
Source: Authors’ figure adapted from Drummond, M., et al, 1997 
 
In the case of the evaluation of EU interventions or more generally in social policy, the 
interventions to be assessed are already in place, and the assignment to these 
interventions is not random, but are allocated to MS in need and follow specific rules. 
Hence, this situation is outside an experimental framework, and appropriate methods 
need to be applied, see Chapter 4. 
1.5 Why is economic evaluation important? 
 
Economic evaluation is important since it is based on the linkage between the inputs and 
the outputs, i.e. the linkage between the interventions funded by the EU and their 
consequences with causal impact evaluation, policy makers are able to assess and 
quantify whether the inputs produce the expected effects, and to help draw conclusions 
on whether the costs of EU interventions are worth the effects. 
Economic evaluation is a systematic analysis method that allows the clear identification 
of relevant alternatives and enables responsible authorities in the EU to make informed 
choices. 
 
Box 1: Aim of this report 
 
This report addresses the three main methodological challenges to tackle when 
performing an economic evaluation of EU funded interventions, especially in the food 
chain area: 
— Measuring costs 
— Quantifying the effects 
— Identifying the causal impact in absence of experimental settings (randomisation). 
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2 Measuring costs6  
 
The evaluation of the interventions’ efficiency within the food chain area requires the 
collection or the availability of information on costs in relation with the achievement of 
the interventions’ objectives. This section discusses how costs should be estimated and 
which types of costs need to be considered in the evaluation, that mainly depend on the 
chosen perspective. 
2.1 The perspective 
 
The evaluation could follow the “budget perspective approach” or “EU funding 
perspective”: the purpose is to help allocate the EU funding budget. This perspective 
considers EU funding only and compares the resources allocated to MS with the effects 
they cause. 
The evaluator could choose a broader perspective called “societal perspective” or 
“decision maker approach” and take into consideration the value of a broader range of 
costs and consequences and present them in a way that helps MS/EU decision makers 
form a better judgement. This perspective uses the economic concept of “opportunity 
cost” which will be explained in more detail in the subsequent sections. 
2.2 Costs to include in the evaluation 
2.2.1 View point and opportunity costs 
 
The costs to include in the evaluation depend mainly on the perspective chosen for the 
analysis. The view point of the evaluation is important as an intervention might be cost-
effective from the perspective of the EU or the MS but not from the point of view of the 
individuals such as farmers. 
If the evaluation considers the EU’s point of view, the costs to account for in the 
evaluation would be the amount of funding the EU allocates to the food chain area. The 
European Commission may also take a broader point of view as the aim of the EU is to 
provide a safe environment of food consumption, assure the health of animal, plants and 
humans, and economic development in Europe. In this societal perspective, the 
evaluation would analyse the costs for the EU but also the costs for the MS and the 
producers and consumers of the food chain area. 
The societal perspective would require the collection and the valuation of private costs or 
expenses but also what is referred to in economics as opportunity costs. Opportunity 
costs are the costs of the time spent on an activity or a task and that cannot be spent on 
another. This cost may include for instance the cost of the farmer that needs culling its 
animals and buy younger animals to replace the culled ones accounting for the time 
needed until the younger animals can be used for production. Farmers might also need 
to invest in materials/lands/buildings or acquire new skills to adhere to the EU control 
and security recommendations. 
  
                                           
6  See Chapter 8 on “Methods, models and costs and benefits” of the Better Regulation tool box gives 
valuable advice on how to identify and assess costs. http://ec.europa.eu/smart-
regulation/guidelines/docs/br_toolbox_en.pdf 
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2.2.2 Follow-up time 
 
The follow-up time deals with how long the costs but also the effects should be tracked 
and included in the evaluation. The follow-up time may not correspond only to the 
duration of the funding period under evaluation but shall be extended until the effects 
and costs are expected to happen. 
In the context of the food chain area, the duration of the follow up period will depend on 
the evaluation question and the chosen outcomes. The type of outcomes (output, result 
and impact indicators) and study question examples will be explained in detail in Chapter 
3 and Chapter 5. 
One may need to control also for cost information from previous funding periods, as the 
outcomes of interest may be affected by interventions or measures implemented before 
the observed effectiveness of the intervention under evaluation. 
 
2.2.3 Costs of the intervention at the margin 
 
Identifying costs related to the intervention is not always straightforward and will 
depend on the level of disaggregation of the cost data. In the case in which 
disaggregated data (at farm, or regional levels) are available, cost data for the 
evaluation should be gathered considering whether, according to the question and the 
scope of the evaluation, the costs related to the intervention reflect additional costs 
compared to the present situation.  
For instance, when an outbreak occurs, farmers are required to move or confine their 
animals in a specific area. This would require resources to contain the animals in 
designated area. If the resources are already available, these costs would not be 
included in the evaluation. 
 
Another type of cost that is difficult to include in the evaluation is the overhead costs, 
such as additional time needed for existing staff or farmers to implement the emergency 
measures. 
 
2.3 Comparability of costs over time and across Member States 
 
When the scope of the cost-effectiveness analysis includes different regions from 
different MS and the evaluation period spans over more than a year, one needs to make 
sure that the costs are comparable across MS. 
Once cost data are gathered, they need to be converted into a common unit adjusting 
for inflation, exchange rates and year of implementation of the intervention, following 
the two steps described below: 
 
1. Common currency: Costs need to be converted into a common currency (Euros) 
using the exchange rates of the year the costs occurred. 
2. Real costs of the analysis year: Costs need to be converted to costs in terms of 
the year of analysis (the current year or the end of the financial period) using 
average annual inflation rates between the ocurrence of costs and the chosen 
common year. For instance, if the year of the analysis is 2013, the costs for the 
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years 2007 to 2012 will be converted to costs in 2013 value using the following 
formula: 
 
Year X =2013 
Year Y= 2007, …, 2012 
 
						 ! = 		 ∗
#$%	&'	()		
#$%	&'	()				
 
 
The index number can be for instance the GDP deflator or the Harmonised Indices 
of Consumer Prices (HICP). 
 
Box 2: Measuring the costs 
 
The costs to include in the evaluation: 
- can be of the following types (the perspective of the analysis): 
A) Only EC level 
B) EC level + MS level 
C) EC level + MS level + Business level 
— additional costs or costs at the margin related the intervention 
— costs in the follow-up time defined as the period until the intervention is expected to 
have an effect 
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3 Measuring effectiveness 
 
This chapter presents a methodology to develop a set of indicators to monitor and 
evaluate the implementation of the CFF spending at different levels of intervention. 
These indicators update and complement the existing set of 21 technical indicators 
currently used by DG SANTE.  
3.1 Definitions 
Developing a framework to assess the cost effectiveness of the EU spending in the food 
chain area under the CFF starts by considering a set of indicators able to provide 
information on the degree of implementation and on the evaluation of the interventions. 
Indicators are quantitative measures of the outcomes generated by the policy 
interventions that are related to the objectives and the intervention logic, and allow 
monitoring, analysing and comparing the performance of an intervention over time, 
across countries or regions etc. 
The general objective of the CFF is to contribute to a high level of health for humans, 
animals, and plants along the food chain and in all related areas. The policies 
implemented in each spending area are designed to achieve the specific objectives 
defined in the Regulation (EU) No 652/2014, through the implementation of a set of 
interventions. 
For the animal and plant health spending areas these interventions are set taking into 
account the recent evolution and current state of plant pests and animal diseases in the 
MS and the possible threats for the EU territory arising from third countries. While in this 
context these interventions take the form of planned actions, on the other hand 
emergency measures are foreseen to address the occurrence of new animal diseases or 
plant pest outbreaks. 
In both cases – planned and emergency measures - the CFF foresees a set of measures 
whose implementation contributes to meeting the (specific and therefore overall) 
objectives that can be substitutes or complements.  
For the purpose of monitoring and evaluation these measures can be considered 
individually or grouped in correspondence with the particular objectives they aim to 
achieve. For simplicity, this hierarchy of interventions that characterizes the spending 
area activities can for simplicity be classified in four levels according to the following 
outline: 
• Level 1: The first level of intervention considers the spending area – animal 
health, plant health and official controls7 
• Level 2: The second level corresponds to the interventions within each 
spending area, as defined in the Regulation (EU) No 652/2014, e.g. 
Emergency measures (in both AH and PH), national veterinary programmes 
(AH), national survey programmes (PH) and the BTSF programme and the 
EURLs activities (OC). For the animal and plant health areas these 
interventions are framed around four main pillars: prevention; surveillance 
and early detection; early reaction and; cure and eradication. 
• Level 3: The third level (sub-interventions) groups and covers measures 
within a given activity that contributes to a particular objective (e.g. 
                                           
7 The interventions funded in animal health, plant and official controls contribute to food safety. As there are no 
specific measures or criteria to ensure food safety except from special guarantees for Salmonella on eggs 
and poultry meat, Trichinella, TSE, BSE, scrapie in certain Member States, indicators specifically for this 
spending area not presented. 
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eradication and containment measures within the veterinary programmes or 
sampling methods within the survey programme for plants). 
• Level 4: Finally, the fourth and lowest level covers measures that can be 
either complementary or substitute in respect to the target defined within a 
given sub-intervention (e.g. decontamination or compensation measures 
within the eradication sub-intervention for animal health)8.  
For each type of intervention the rational for the choice of the indicators is described in 
two steps. First, a brief summary of the intervention is provided to establish the link 
between the objectives of the intervention and its corresponding targets. Secondly, the 
set of indicators associated with the targets is proposed, according to a classification 
presented and discussed in the following sub-sections. 
3.1.1 The intervention summary 
The intervention summary provides a characterisation of how the intervention is 
expected to work. Understanding and defining the scope of the actions to be undertaken 
allows establishing a link between the measures and the targets to be achieved. 
Therefore for each level of intervention relevant concepts are defined in a sequential 
order leading to the definition of the target(s): 
1) Intervention: this could be either a programme when considering the different 
components of the spending area, a sub-programme within a programme, or a 
measure when considering the different components of a particular sub-
programme in each spending area9. 
2) Description: the nature of the actions to be undertaken given the type of 
intervention10. 
3) Objective: given the description it identifies the goals the intervention is expected 
to achieve. This is often a qualitative achievement or the achievement of a given 
condition/status. 
4) Preliminary CFF indicators: these are the indicators (although not always directly 
measurable) defined in the CFF Regulation that can be associated to the 
intervention. 
5) If no action: given the description of the intervention and its objective it defines 
the expected outcomes with respect to the case if the intervention were not to be 
implemented. 
6) Targets: statement of the objectives susceptible of being measured and 
quantified.  
These definitions allow linking each intervention with its associated target. However, 
depending on the level of the intervention considered, a set of interventions can be 
associated with the same target, e.g. all compensation measures within eradication 
programmes are devised to provide incentives for the reporting of diseases.  
3.1.2 Indicators and outcomes 
Indicators are used to analyse the performance of a policy according to its objectives and 
targets while informing on several dimensions of its implementation. In particular, for 
spending programmes in the CFF it is of interest to measure the level of implementation 
of each activity, i.e. how many measures were implemented, as well as the outcomes of 
such actions.  
                                           
8 In the present report, indicators at this level are not presented but could be developed. 
9 In order to ease the notation and terminology, any of these types of interventions will generically be referred 
to as `intervention’ or `measure’ from this point onwards. 
10 Note the EU co-funding is awarded only to some expenses related to the actions/measures. 
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With respect to the type of outcome, indicators can be grouped into two categories: 
technical indicators (as listed in the operational technical indicators for the AH, PH, BTSF 
and EURL activities) and impact indicators. Technical indicators measure the outcomes 
that are directly related to the interventions and can be classified as output and result 
indicators. Impact indicators allow identifying relevant indirect economic and/or social 
outcomes induced by the interventions. 
Output indicators 
Output indicators relate directly to the implementation of an intervention, i.e. they are 
measurable deliverables from the interventions that need to be generated in order to 
achieve its objectives11.  
These indicators are informative on how the funds have been spent without reference to 
the intended outcome of the intervention. However, in some cases the mere 
implementation of a given action might in itself be an important desirable outcome (e.g. 
having all MS running surveys to detect plant pests, or awareness campaigns). 
Result indicators 
Result indicators aim at monitoring and evaluating what the policy intervention intends 
to achieve. They represent changes over the short, medium and long term which can be 
directly linked to the intervention’s ability to address the identified problems and their 
drivers. 
These indicators measure the immediate positive or negative effects of the intervention. 
These indicators aim at assessing the direct impact of the co-funded measures and 
therefore link the funding with the achievements of the policy targets. 
When considering the measurement of these outcomes, it is crucial to distinguish 
between short-term and long-term policy effects, as some interventions are 
implemented in a multi-annual perspective in view of the characteristics of the issues to 
be addressed. For instance, eradication programmes for certain animal diseases can take 
several years to produce results.  
Despite providing valuable information to monitor the progress towards the target at any 
point in time, scheduling early effectiveness assessments could be misleading. This is 
especially the case if the minimum time necessary for the intervention to have an actual 
and tangible effect has not been taken into account.  
Impact indicators 
While result indicators concern the direct effects of a given intervention, impact 
indicators aim at monitoring the relevant indirect effects on economic, social and health 
outcomes (e.g. livestock production losses, disruptions in trade, or, in case of zoonosis, 
the impact on human health and the costs to the health system). They represent 
changes over the short, medium and long term which can be linked to the intervention, 
and should be closely related to the identified problems and drivers. 
3.1.3 Indicators and policy cycle 
Monitoring and evaluation of the EU funded food chain measures can and should be done 
at different stages of the policy cycle by using the appropriate set of indicators.  
Depending on the stage of the policy cycle at which the indicators are computed, they 
can provide information on either the expected, actual or final performance of the 
intervention. Specifically, they might be used to: ex-ante assess the effect of the 
proposed actions; assess whether (and the extent to which) those actions are being 
taken and; evaluate the returns from those actions. 
                                           
11 As defined by the Tool #41, Monitoring Arrangements and Indicators, within the European Commission 
‘Better Regulation Toolbox’ (https://ec.europa.eu/info/sites/info/files/file_import/better-regulation-
toolbox-41_en_0.pdf) 
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At different stages of the policy cycle – before, during and after - the performance of the 
intervention requires employing the appropriate indicators.  
Before the intervention 
At this stage it is relevant to consider indicators that: (i) allow the computation of the 
expected cost of the interventions for budgetary purposes and; (ii) assess the impact of 
the proposed interventions in order to justify its implementation.  
The first objective can be achieved through computation of the expected output 
indicators, while the second can be addressed by considering the expected, result or 
impact indicator. Both expected indicators can be computed on the basis of technical 
characteristics or more plausibly from previous evaluation exercises of similar 
programmes.  
Consideration of these indicators at this stage of the policy cycle is particularly relevant 
where alternative interventions addressing the same target are available or where 
programmes are designed in a context of scarce resources or lack of priorities. 
During the intervention 
At this stage, given that policy choices have been made, the aim of the indicators are 
informative for monitoring the implementation of the intervention, comparing the actions 
that have been taken with the ones proposed by the intervention and possibly correcting 
its path. This type of activity is especially important when the implementation of the 
intervention is done in a multi-annual framework. 
In this context it is particularly relevant to compute output indicators to assess how the 
proposed actions are being implemented and, result indicators able to measure the 
effectiveness of the intervention and to provide information on the possible need to 
correct its path. 
After the intervention 
At this final stage of the policy cycle, the main purpose of the indicators is to evaluate 
the interventions. Result and impact indicators are the most relevant as they are 
designed and computed to assess the performance of the actions taken and compare it 
with the prospective targets. 
These indicators can also be used as benchmark to guide the policy choices to be made 
in the subsequent policy cycle.  
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3.2 Technical indicators for the CFF spending areas 
This section presents the set of technical indicators for the CFF spending areas following 
the methodology proposed in the previous section12. The chosen indicators update and 
complement the existing set of 21 technical indicators currently defined by DG SANTE.  
The choice of the indicators is motivated by providing, firstly a summary of the 
intervention that leads to a description of the targets it is designed to achieve. Some 
targets are implicitly defined by the existing CFF indicators, while new targets may be 
suggested from the description of the programmes.  
Secondly, the existing indicators are classified in the proposed framework while new 
ones are suggested so that, all programmes are monitored and evaluated with both 
output and result indicators. 
The proposed indicators can be computed at the different stages of the policy cycle as 
discussed in section 3.1.3.  
The indicators will be assigned a code that identifies: the spending area, the hierarchical 
chain of programmes within the spending area, the type of indicator, the associated 
target, and the number of the indicator. (e.g. AH.NV.ER.B.O1 represents output indicator 
number one for target B of the eradication under National veterinary programme of the 
animal health spending area).  
Text in italics corresponds to concepts defined by DG SANTE such as already existing 
technical operational indicators, operational objectives etc. 
3.2.1 Technical indicators for plant health 
Table 1 summarises the survey programmes and emergency measures (up to the third 
intervention level) that lead to the targets definition.  
Under the survey programmes two targets are considered: target A is implicitly defined 
by the already existing CFF indicator and target B aims to monitor and evaluate the 
programmes ability to detect the presence of HOs. 
For the emergency measures the targets differ according to whether the MS submits an 
eradication or a containment programme. 
Table 2 presents the output and result indicators for both National survey programmes 
and emergency measures associated with the targets defined above. 
Both output and result indicators can be expressed in relative terms with respect to the 
appropriate quantities (e.g. by area in ha, by no. of farms, etc.) 
 
The indicators definition is in most cases self-explanatory but some remarks are due to 
further clarify its content: 
 PH.NS.O.B: Survey actions are the set of the activities under sampling - visual 
inspections, sampling or trapping - and testing used to identify specific HOs (e.g. 
a survey action could perform visual inspections and trapping activities to identify 
the presence of harmful insects)13. This would be a measure of how many times 
potential plant pests are surveyed.  
 PH.NS.R.B5: This indicator relies on the definition of early actions. These are 
foreseen in the operational objective (ii) that suggests “… early appropriate 
actions against the presence of pests…” will be taken upon the detection of an 
                                           
12 The impact indicators, including the indicators regarding human health aspects will be discussed in the 
section 3.3 
13 At the time of application MS must supply data on the expected actions to be taken of these type (see 
Annex: Guidance by MS for the preparation of SP for pests for 2015) 
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HO. Depending on the nature of the actions to be taken, these early actions could 
be designed to prevent the occurrence of an outbreak. 
 PH.E.ER.R3: Measuring the timing of eradication or containment requires a 
continuous updating of the plant pest status following the detection of a pest. 
 
Computation of these indicators relies on: (i) available data from MS survey programme 
submissions and MS Reports and (ii) on data collected from the alert system 
(EUROPHYT-Outbreaks) implemented to monitor the plant pest status in the EU 
territory14. 
                                           
14 Given the obligation to notify the presence of HOs (article 16 of Directive 2000/29/EC) an effort has been 
done to develop monitoring tools for the Notification of Harmful organism outbreaks in the EU. MS have to 
notify the presence of HOs and update those notifications to “… provide complementary information on a 
previous outbreak notification. This information can be related to spread, the successful eradication or any 
other development or information that was not available at the time of the notification of the harmful 
organism”( in Harmful Organisms in the EU: Annual Report 2014). 
EUROPHYT-Outbreaks is based on Commission Implementing Decision 2014/917/EU setting out detailed 
rules for these notifications. It was designed and developed by the Commission with the support of a 
number of Member States, Switzerland, the European Plant Protection Organisation (EPPO) and the 
European Food Safety Agency (EFSA). It is aimed at supporting Member States in their reporting 
obligations while ensuring that comprehensive and harmonised data is provided and distributed to all 
official plant health services within the EU. 
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Table 1: Survey programmes and phytosanitary emergency measures 
Intervention Survey programmes 
Emergency measures(1) 
Eradication Containment 
Description Surveys to detect the presence of HOs in plants (Refund of ) Actions taken to timely eradicate/contain PESTS once they have entered 
the EU territory 
Aim Ensure early detection for taking  immediate measures for the ERADICATION of the 
outbreaks or, if this is no longer feasible, at least ensure CONTAINMENT with the 
aim to protect the rest of the EU territory 
Avoid the spread of an Outbreak: Hence 
identified encourage the swift 
implementation of actions to eradicate the 
presence of HOs. 
Avoid the spread of an Outbreak: Hence 
identified if ERADICATION is not 
possible encourage the implementation of 
actions to contain the presence of HOs in a 
part of the Union territory. 
Operational 
objectives 
(Annex 1 to the CID 
C(2016)  2465 final) 
i. Timely identify and detect emerging risks as regards non listed pests which 
represent an imminent or potential danger for the EU territory.  
 
ii. Ensure the early and appropriate action against the presence of pest 
iii. Improve the functioning of the EU plant health legislation by monitoring the risks of pests listed in Directive  2000/29/EC, after interception of imported commodities 
infested with pests  (This operational objective does not relate to any of the measures in the programmes) 
CFF indicators CFFI 3.1: Coverage of the EU territory by surveys for PESTS in particular Not 
Known to Occur (NKO) and Most Dangerous (MD). 
CFFI 3.2: Time and Success rate for the eradication of PESTS. 
If no Action Passive surveillance Spread of outbreaks  
Targets 
A. Guarantee Full EU Coverage(2) 
B. Obtain confirmation about the pest status of a pre-defined list of HOs: 
Eradication of the pest/plant pest Containment of the pest by preventing its 
further spread in the rest of the Union 
territory  
 
1. Pests NKO in EU (listed in Directive 2000/29/EC) 
2. Pests subject to EC measures (article 16(3) of Directive 2000/29/EC) 
3. The potato pests subject to the measures laid down in Directives 
69/464/EEC, 93/85/EEC, 98/57/EEC and 2007/33/EC 
4. Pests not listed in Directive (NLD) 2000/29/EC that represent imminent 
danger or EU 
 (1) These are phytosanitary Emergency Measures, aimed at timely cope with emergency situations related to Plant Health (see Note for the attention of the members States of the Management Board: Future funding of EU 
safety policies (beyond 2020)). MS need to notify and there might be UPDATES of the notification that “… provide complementary information on a previous outbreak notification. This information can be related to 
SPREAD, the SUCCESSFUL ERADICATION or ACTIVE CONTAINMENT or any other development or information that was not available at the time of the notification of the harmful organism”.(Harmful Organisms in the 
EU: Annual Report 2014.) 
 (2) See Commission Implementation Decision of 29.5.2015 “On the adoption of the financing decision for the years 2016 and 2017 for the implementation of veterinary programmes for animal diseases and zoonoses and for the 
year 2016 for the implementation of survey programmes for pests”. 
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Table 2: Output and result indicators for plant health programmes 
 
Intervention Survey programmes 
Emergency measures 
Eradication Containment 
Output 
Indicator (OI):  
 
PH.NS.O.A1: (Increase) No. of  MS covered (running the Surveys) for pests 
NKO (T.I. 3.1a – Category A WP 2017-2018) 
PH.NS.O.A2: (Increase) No. of MS covered (running the Surveys) for pests 
MD (T.I. 3.1b - Category B WP 2017-2018) 
PH.NS.O.A3: (Increase) No. of  MS covered (running the Surveys) for pests 
NLD 
PH.NS.O.B1: Total No. of Surveys actions implemented 
PH.NS.O.B2: Total number of survey programmes implemented 
PH.E.ER.O1: No. of  eradication 
measures put in place 
 
PH.E.C.O1: No. of  containment 
measures put in place 
 
 
 
Result indicator 
(RI):  
PH.NS.R.B5: No. of times actions were taken following the detection of a 
pest by a Survey 
PH.NS.R.B6: No. of outbreaks detected in regions covered by survey 
programmes (measured by the submission of emergency measures 
programmes) 
PH.NS.R.B7: No. of outbreaks of PESTS covered by EU legislation (T.I.3.2) 
PH.NS.R.B8: Number of MS free from the pest/outbreaks  
PH.NS.R.B9: Number of cases of PEST. 
 
PH.E.ER.R1: No. (or %) of 
successful eradication measures(2)  
PH.E.ER.R2: (Average) time to 
eradication status of pest/outbreak 
 
 
PH.E.C.R1: No (or %) of successful 
containment measures(2) 
PH.E.C.R2: (Average) time to 
containment  
PH.E.C.R3: (Average) time the rest of the 
Union territory has been kept free from 
the pest under containment 
 
Plant Health (PH); National Survey Programme (NS); Emergency Measures (E); Eradication (ER); Containment (C); Output indicator (O); Result indicator (R). 
(1) This can be collected from the technical reports (final and intermediate) on the implementation of the Survey Programmes (SP) that MS submit. 
(2) The “HO in the EU” report (https://ec.europa.eu/food/sites/food/files/plant/docs/phb_ho_annual_report_2015-6_en.pdf) describes how MS should continuously report on the developments of the 
PEST outbreak. In particular they should also report when the pest is considered to be controlled, therefore it is possible to measure if and when the PEST is to be considered as eradicated/contained.  
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3.2.2  Technical indicators for animal health 
Table 3 summarises the National veterinary programmes (up to the third intervention 
level) and emergency measures main features that lead to the targets definition.  
Eligibility for a given programme depends on the MS disease status at the time of 
submission. These are currently defined in WD 10186/2017 that also identifies for each 
disease/country the expected results to be achieved by the interventions. This 
description has been used to assign the animal diseases to the appropriate National 
veterinary sub-programmes (eradication or control) as summarised in the last row of 
Table 3. If the expected result for a disease in a given country is “disease FREE” the 
intervention is labelled as an eradication programme, if instead it aims at achieving a 
given herd prevalence or incidence or any other disease parameter (different from zero) 
than it is assigned to a control programme. 
Control programmes apply whenever the prospect of eradicating the disease in the short 
run is reduced. In such cases depending on the epidemiologic characteristics of the 
disease, current status and the time frame considered an animal disease specific disease 
parameter should be considered when measuring the achievement of the target. 
The animal diseases eligible for emergency measures are listed in Annex I to Regulation 
(EU) No 652/2014.  
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Table 3: Veterinary programmes and emergency measures 
 Veterinary programmes 
Emergency measures 
Intervention Eradication Control Surveillance 
Description(1) Actions taken to result in biological 
extinction of an animal disease or 
zoonosis, already present in the 
territory 
Actions taken to obtain or maintain 
prevalence of an animal disease or zoonosis 
below a sanitary acceptable level  
Actions taken to collect and record data 
on specific diseases in defined 
populations over a period of time, in 
order to assess epidemiological 
evolution  of the diseases and the ability 
to take targeted measures for control and 
eradication 
Actions taken as a result of 
confirmed occurrence of a number of 
listed diseases likely to constitute a 
threat for the EU due to their 
significant impact. 
Aim 
 
Free MS from diseases that might 
have impact on health and trade 
Minimise the occurrence of outbreaks and 
reduce and/or control the occurrence of 
animal diseases 
 
Monitor the evolution of diseases to act 
swiftly to avoid outbreak possibility in 
advance 
Prevent or eradicate the occurrence 
of animal diseases. 
Avoid further spread of the animal 
diseases.(3) 
Operational 
objectives(2) 
 
   
If no Action Spread or presence of diseases Presence or spread of diseases Late detection of diseases  Spread of the outbreaks 
Targets  Becoming free from a disease An overall reduction of disease j parameters(4) Fully detect the presence of animal 
diseases and avoid outbreaks 
Timely become free following the 
occurrence of a disease.  
Diseases 
(according to WD 
SANTE/2017/10186) 
TB, O&CB, , Rabies, CSF, ASF, 
BSE,CS 
TB, O&CB, BB,BT, Rabies, CS, BSE, ZS, AI, LSD, PPR and, S&GP Annex I to Reg. (EU) No 652/2014 
Bovine Brucellosis (BB); Ovine and Caprine Brucellosis (O&CB);  Bovine Tuberculosis (TB); Classical Swine Fever (CSF); Lumpy Skin Disease (LSD); Sheep and Goat Pox (S&GP); Peste des Petits Ruminants (PPR);  African 
Swine Fever (ASF); Classical BSE (BSE); Classical Scrapie (CS);  Zoonotic Salmonella in certain Poultry Populations (ZS); Avian Influenza (AI) and; Bluetongue Disease (BT).  
(1) Operational objectives are defined in WD SANCO/1081/2014Rev consistent with the priorities set in the more recent version WD SANTE/2017/10186  
(2) 
 As defined in https://ec.europa.eu/food/funding/animal-health/national-veterinary-programmes_en 
(3) 
 As defined in article 1 of CID C(2016) 4840 final of 29.7.2016 (objectives and results). 
(4) 
 Expected results are listed in the WD 10186/2017 
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Table 4: Output and result indicators for animal health programmes 
 
 Veterinary programmes 
Emergency measures 
Intervention Eradication Control Surveillance 
Output Indicator 
(OI):  
 
AH.NV.ER.O1: No. of 
eradication programmes 
implemented (by disease). 
AH.NV.CR.O1: No. of control programmes implemented 
(by disease) 
 
AH.NV.S.O1: No. of surveillance programmes 
implemented (by disease). 
AH.EM.O1: No. 
emergency measures 
implemented by MS (by 
disease) 
Result indicator 
(RI): 
 
   
(according to Disease 
Parameters in WD 
SANTE/2017/10186) 
 
No. of non-affected/free MSs Herd 
Inciden
ce/Preva
lence 
(%) 
No. of non-
affected/fre
e MS 
No. of 
Cases 
(at the EU 
level only) 
No. MS 
with 
negligible 
risk(1) 
MS in all 
PP 
below 
EU 
targets(2) 
% of Secondary outbreaks 
in domestic birds No of outbreaks 
AH.EM.R1: No. (%) of 
Successful Emergency 
measures  
AH.EM.R2: No. 
secondary outbreaks 
Diseases  
 
TB, O&CB, Rabies, CSF, 
ASF, BSE,CS 
TBO & 
CBBB, 
BT and 
ZS 
CS BT Rabies, 
BSE, BT 
BSE ZS AI LSD, PPR and, S&GP 
 
AH.NV.ER.R1: (An increase 
in the) No. of MS or their 
regions free from disease (T.I. 
2.1a,d) 
AH.NV.ER.R2: No. (%) of 
MS/regions that became free 
from a disease 
j= TB, O&CB, BB,BT, Rabies, CS, BSE, ZS,  j= AI, LSD, PPR and, S&GP 
AH.NV.C.R1.j: Distance to the disease parameter as 
defined in WD SANTE/2017/10186 
AH.NV.C.R2.j: No.(%) of times target (in the WD 
SANTE/2017/10186) for disease j was achieved 
AH.NV.C.R3: No. of times target (in the WD 
SANTE/2017/10186) for all diseases was achieved (results 
from aggregating AH.NV.C.R1.j) 
AH.NV.S.R1.j: Distance to the disease parameter as 
defined in WD SANTE/2017/10186 
AH.NV.S.R2.j No.(%) of times target for disease j was 
achieved 
AH.NV.S.R3: No. of times target for all diseases was 
achieved (results from aggregating AH.NV.S.R2.j) 
AH.NV.S.R4.j: No. of times early actions taken following 
the detection of disease j through a Surveillance Programme 
(by disease) 
AH.NV.S.R5.j: No. of diseases j outbreaks in regions 
covered by Surveillance Programmes  
Animal Health (AH); National Veterinary Programme (NV); Control & Eradication (C); Eradication (ER); Emergency Measures (EM); Surveillance (C); Output indicator (O); Result indicator (R);  
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Table 4 presents the output and result indicators for both Veterinary programmes and 
emergency measures associated with the targets defined in Table 3. 
Again, both output and result indicators can be expressed in relative terms with respect 
to the appropriate relevant quantities (e.g. by no. of animals or holdings at risk, etc.) 
The current list of operational technical indicators for animal health in the WD 
SANTE/2017/10186 does not cover all diseases for which expected results and therefore 
targets are defined. As such, indicators based on those parameters are proposed to cover 
all animal diseases under the Control and Surveillance Programmes: 
 AH.NV.C.R1.J and AH.NV.S.R1.J: These set of result indicators (R1) are disease (j 
index) and country specific and depend on to the definition of the relevant disease 
parameter in the WD SANTE/2017/10186. 
 AH.NV.C.R2.J, AH.NV.C.R3 and AH.NV.S.R2.J, AH.NV.S.R3: These indicators are unit free 
to allow for comparisons on the monitoring and evaluation of the different 
diseases (R2) and, the computation of an aggregated indicator (R3) able to 
monitor the evolution of all diseases. 
The additional indicators for surveillance programmes assume the availability to 
continuously monitor the disease status: 
 AH.NV.S.R4.J and AH.NV.S.R5.J: These indicators rely on both the identification of 
early actions taken to prevent the outbreak of the disease after it has been 
detected by a surveillance measure (R4) and on the effective reporting of the 
disease outbreaks (R5)15 
 
3.2.3 Technical indicators for official controls 
The EU co-funding of the EURL covers two main areas: (i) the costs incurred by the 
laboratories of implementing the work programmes approved by the EC and; (ii) training 
activities for the staff of the competent authorities responsible for official controls. 
Despite both types of activities contribute to the specific objective set for this spending 
area, namely “… to improve the effectiveness, efficiency and reliability of official 
controls…”, the set of indicators already existent and the proposed ones focus on the 
monitoring and evaluation of the training measures, since the qualification of the official 
controllers is the crucial condition for its achievement. 
Under training two main activities are co-funded in the CFF: Better Training for Safer 
Food, where three types of interventions are considered - Workshops, e-learning and, 
Sustained Training Missions (STM) - and Proficiency Tests (PT) administered and 
workshops provided to the national EU Reference Laboratories16.  
 
Table 5 summarises both the interventions under BTSF and EURL and its associated 
targets. 
The targets assume that participation in all training activities is compulsory and that the 
attendees are assessed both before and after the courses. This is needed in order to 
allow measuring the effectiveness of these interventions. In particular the targets 
assume that the officials attending the workshop will be responsible for teaching (directly 
                                           
15 The existence of a notification system where information on measures taken to address the presence of a 
disease is reported should provide such data. (e.g. some diseases like AI are notifiable to the OIE and must 
therefore be reported). 
16 While in the current framework enrolment by the National Laboratories for the PTs is voluntary here 
compulsory participation will be assumed since harmonisation of the control procedures and increased 
coordination is a goal to be achieved by this funding area. 
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or indirectly) the same contents to the National experts. The National experts would then 
be subject to an assessment by the EU. 
Table 6 presents the output and result indicators for both BTSF and EURL interventions 
associated with the targets defined in Table 5.  
 The consideration of the second result indicator for target A (xxx.R.A.2) allows 
measuring the effective contribution of the training to the increase in the technical 
skills of participants.  
 The computation of the success and satisfaction rates of all result indicators can 
conducted as follows: 
o Define an individual/laboratories target for the test score. The target 
should be a minimum score greater than 50%.  
o The success and satisfaction rates are measured by the percentage of 
individuals/laboratories above the target. This rate could be computed at 
the national and/or EU level. 
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Table 5: Activities of official controls 
 Better Training for Safer Food(1) EU reference laboratories 
Intervention Workshops e-learning Sustained training 
missions 
Proficiency tests (PT) EURLs Workshops  
Description EC organised training courses in host 
countries for the staff of the competent 
MS authorities responsible for the 
official controls:  case studies, 
discussions, site visits and practical 
work and tests with assessment 
EC organised e-
learning training 
sessions 
Complement to 
workshops to help 
countries in areas where 
deficiencies have been 
found 
Administration of Proficiency testing (PT) amongst 
National Reference Laboratories (NRL’s) and other 
international laboratories, allowing a laboratory to 
assess its performance against, through testing its 
ability to detect various (bacteriological) disease 
parameters  
EC organised workshops addressing 
current practice and future directions of 
PT, which may include lectures or 
training courses and discussions in 
working groups 
Aim 
 
To keep MS competent authorities up-to-date with all aspects of Union law in the areas 
specified above and ensure that controls are carried out in a more uniform, objective and 
adequate manner in all Member States 
To ensure high-quality, uniform testing in the EU 
and support Commission activities on risk 
management and risk assessment in the area of 
laboratory analysis  
To improve the organisation and promote 
best practice of proficiency testing, 
providing organisers and users of PT a 
forum for issues and activities related to 
PT. 
Operational objectives 
 
The main objective of the initiative "Better Training for Safer Food"(1) is the organisation 
and development of a Community training strategy with a view to:  
• Ensuring and maintaining a high level of consumer protection and of animal 
health, animal welfare and plant health;  
• Promoting a harmonised approach to the operation of Community and national 
control systems;  
• Creating an equal level playing field for all food businesses; 
• Enhancing trade of safe food;  
• Ensuring fair trade with third countries and in particular developing countries 
Reference Laboratories (2) are tasked to: 
 
•Provide National Reference Laboratories (NRLs) 
with analytical methods and diagnostic technics, 
and coordinate their application 
•Train staff from National Reference Laboratories 
•Provide the Commission with scientific and 
technical expertise in relation to laboratory analysis 
(e.g. assist actively in the diagnosis of animal 
disease outbreaks) 
•Collaborate with the competent laboratories in 
non-EU countries 
The organisation of international 
workshops on PT provides for: 
• Enabling interactive participation 
and cross-fertilisation of ideas 
among participants 
• Preparing discussion documents, 
guides and information leaflets on 
topics related to PT 
• Collaborating with other 
international groups with regards 
to PT 
If no Action Lack of harmonisation of control procedures and lower rate of updating of control skills 
Targets A. High scores in the tests performed 
after the training 
B. Satisfaction of participants  
C. High scores of national experts 
attending training administered by 
participants in EC workshop  
A. High scores in the 
tests performed 
after the training 
B. Satisfaction of e-
participants  
 
A. High scores in 
the tests 
performed after 
the STM 
B. Participants 
satisfaction 
 
A. High scores of proficiency test 
B. Efficient learning 
C. Satisfaction of participants 
 
A. High scores in the tests performed 
after the training 
B. Satisfaction of participants 
 
(1) As defined in http://ec.europa.eu/chafea/food/about.html 
(2) As defined in https://ec.europa.eu/food/safety/official_controls/legislation/ref-labs_en 
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Table 6: Output and Result Indicators for official control activities 
 
 Better Training for Safer Food(1) EU Reference Laboratories 
 
Intervention Workshops e-learning Sustained Training 
Missions 
Proficiency Tests (PT) EURLs Workshops 
Output Indicator 
(OI):  
 
OC.W.O.A.1: No. of workshop participants 
OC.W.O.A.2: No. of workshops  
OC.W.O.C.1: No. of national experts attending 
workshop related training 
OC.W.O.C.2: No. of national workshops related 
trainings 
OC.e-l.O.A.1: No. of 
e-learning training 
participants 
OC.e-l.O.A.2: No. e-
learning training 
courses  
OC.STM.O.A.1: No. of 
STM participants  
OC.STM.O.A.2: No. of 
STM 
 
OC.PT.O.A.1: No. of PTs 
(by lab type) 
OC.LW.O.A.1: No. of 
workshop participants 
OC.LW.O.A.2: No. of 
workshops  
OC.LW.O.A.1: No. of 
international experts 
attending workshop related 
training 
OC.LW.O.A.2: No. of 
international workshops 
related trainings 
Result Indicator (RI):  OC.W.R.A.1: Success rate of the tests performed  
 
OC.W.R.A.2: Improvement rate compared to initial 
score 
 
OC.W.R.B: Overall satisfaction rate of workshop 
participants  
 
OC.W.R.C1.1 Success rate of the tests performed on 
national experts  
OC.W.R.C2.2 Improvement rate compared to initial 
score  
OC.W.R.C: Overall satisfaction rate of participants 
attending the training  
OC.e-l.R.A.1: Success 
rate of the tests 
performed  
 
OC.e-l.R.A.2: 
Improvement  rate 
compared to initial 
score 
 
OC.e-l.R.B: Overall 
satisfaction rate of 
participants attending 
the e-learning 
OC.STM.R.A.1: Success 
rate of the tests performed  
 
OC.STM.R.A.2: 
Improvement  rate 
compared to initial score 
 
OC.STM.R.B: Overall 
satisfaction rate of 
participants attending the 
training  
 
OC.PT.R.A.1: Success rate 
of proficiency test, including 
the correct follow-up in cases 
of underperformance (for 
each lab)                                                       
  
OC.PT.R.A.2: Improvement 
rate compared to initial score   
OC.PT.R.B: Number of PT 
retakes 
 
OC.LW.R.A.1: Success 
rate of the tests performed  
OC.LW.R.A.2: 
Improvement rate 
compared to initial score    
 
OC.LW.R.B: Overall 
satisfaction rate of 
workshop participants  
 
 
Official Controls (OC); Workshops (W); e-learning (e-l); Sustained Training Missions (STM); Proficiency Tests (PT); EURLs Workshops (LW); Output indicator (O); Result indicator (R) 
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3.3 Impact indicators  
The evaluation of the effect of the EU interventions should also be conducted on outcome 
indicators that reflect their impact from an economic and health perspective. In 
particular, three broad themes have been considered: production, trade and human 
health.  
3.3.1 Production: productivity and production losses 
First the potential impact indicators from the point of view of the producers are 
discussed. Specifically, it might be relevant considering indicators that pertain to 
productivity, production losses and investments. All these outcomes might be evaluated 
at different levels, namely at the firm, sector or regional level. The choice of the most 
appropriate level is strictly intertwined with the specific features and assumptions of the 
impact evaluation method employed17. 
The effect of plant pests and animal diseases in a given production system is a reduction 
in the efficiency with which inputs and resources are converted into outputs and 
products. In other words, pests and diseases decrease productivity within the farm18.  
Animal health  
Indicators to monitor production from the livestock resources usually consider the 
following commodities: meat, milk, eggs and wool produced by animal species. Possible 
indicators to measure commodity-specific productivity are: 
AH.I.PD.J - Production density (for commodity j): density of total production for each 
commodity produced (meat/milk/eggs and wool). This is the quantity (volume/value) 
produced divided by total (agricultural) land. Since the denominator is not affected by 
the possible mortality this measure is relevant if the impact of diseases on the productive 
chain is to be accounted for.  
AH.I.P1.J - Production by animal (for commodity j): average production for each 
commodity (meat/milk/eggs). This is the quantity (volume/value) produced divided by 
the total no. of animals. If measured in value, it could be measured as total livestock 
output/Livestock Unit (LU) (as defined in the FADN data base)19. 
When measured in value, these indicators may incorporate price changes due to 
potentially reduced quality of the output. Hence, if both input and output are measured 
in monetary terms, the indicators would constitute a measure of the economic value of 
output.  
Another advantage of considering monetary output instead of physical output is that a 
production system (farm/holding) uses many different kinds of input and produces 
several kinds of output, especially in the case of livestock systems. A productivity 
indicator that takes that into account is: 
                                           
17 Data on production, input cost, and investment is available at the Farm Accountancy Data Network (FADN) 
collected at farm level. 
18 Throughout this section the following codes represent: Impact indicator (I); Production Density (PD); 
Production (P); Production Losses (PL); Private Investment (PI); Exports (X); Net Exports (NX); Quantity 
(Q); Value (V); Food Safety (FS); Human Health (HH);  
19 The livestock unit, abbreviated as LSU (or sometimes as LU), is a reference unit which facilitates the 
aggregation of livestock from various species and age as per convention, via the use of specific coefficients 
established initially on the basis of the nutritional or feed requirement of each type of animal (see 
http://ec.europa.eu/eurostat/statistics-explained/index.php/Glossary:Livestock_unit_(LSU)). 
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AH.I.P2.J - Total output divided by total input (for commodity j): both are measured in 
monetary units and can be collected at farm, regional or country level (through 
aggregation). 
Additionally, it is of interest to measure how EU funding impact on animal health. 
Indicators to monitor livestock health should describe not only the disease status of a 
region but should also include information on slaughtered or destroyed animals by animal 
disease. An indicator to measure production (livestock) losses is: 
AH.I.PL.J Production (livestock) losses: total no. of animals affected by disease (sick 
animals + animals that died from the disease) by specie in volume or value. 
Plant Health 
Possible indicators to measure commodity-specific productivity in plants and plant 
products potentially affected by diseases or pests funded by the EU are: 
PH.I.PD.J - Production density: density of total production for each type of plants 
(product). This is the quantity (expressed in volume or value) produced divided by total 
(agricultural) land (ha)20.  
As measured in the case of animal health, if output and input are measured in value, the 
productivity indicator would then be: 
PH.I.P1.J - Total output divided by total input: both are measured in monetary units and 
can be collected at farm (relevant), regional or country level (through aggregation). 
3.3.2 Private investment 
The use of farmer’s private investment as an indicator is relevant to evaluate the impact 
of the intervention on their capability to keep up with the innovation in technology in the 
sector.  
Private investments encompass operations that aim at renovating and/or expanding the 
farms physical assets such as buying new farm equipment and machinery, constructing 
farm buildings, improving the land, etc., or at enhancements in human capital (e.g. 
undergoing specific training). These operations, in turn, often translate into increased 
health of plants and animals, better quality of the products, higher farm productivity and 
reduced waste and emissions into the environment21. 
The following measures are good candidates to be used to proxy changes in private 
investments in the agricultural sector (both livestock and plants): 
PH/AH.I.PI1 - Number of machinery owned by the farm (exclusively or used by several 
holdings) by size of farm; 
PH/AH.I.PI2 - Physical and/or economic size of the agricultural holdings; 
PH/AH.I.PI2 - Gross fixed capital formation in agriculture (investments in assets which are 
used repeatedly or continuously over a number of years to produce goods in agriculture);  
PH/AH.I.PI2 - Number of farm managers who underwent full agricultural training. 
  
                                           
20 If the output is measured in monetary terms, this indicator would coincide with the measure suggested by 
FADN (total crops output / ha). 
21 Potential sources of information about private investments in farms are found within the Farm Structure 
Surveys (http://ec.europa.eu/eurostat/web/agriculture/farm-structure) and the Monitoring and Evaluation 
Framework for the CAP 2014-2020 (source: common context indicators for rural development programs, 
CAP context indicators, https://ec.europa.eu/agriculture/cap-indicators/context_en). 
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3.3.3 Trade 
The spread of animal diseases and plant pests can have an effect on trade even in the 
short run, through changes in both supply and demand22. The export indicators show 
how each country manages to sell its product to other countries. A country’s trade 
balance position (net exporter or net importer) is an important indicator of food security 
and stability of a country. The trade balance can be estimated as the difference between 
exports and imports both in monetary and quantity terms.  
Possible indicators to measure trade are:23  
PH/AH.I.X.Q – Export in volume quantity: collected by country, both for animals (dairy 
products/eggs/meat and livestock) and for crops (where the categories are defined by 
DG SANTE). 
PH/AH.I.NX.Q – Net export in volume quantity: collected by country, both for animals and 
animal products and for crops. 
When measured in value, these indicators need also to incorporate price changes.  
PH/AH.I.X.V – Export in monetary value: collected by country, both for animals and animal 
products and for crops. 
PH/AH.I.NX.V – Net export in monetary value: collected by country, both for animals and 
animal products and for crops. 
3.3.4 Human health 
According to the last report on the global burden of foodborne diseases by the World 
Health Organisation in 2015, 23 million people are affected by foodborne diseases every 
year, including 5000 deaths in the WHO European region.24 Clearly, this makes food 
safety a public health priority for any country and any cross-national institution.  
Possible indicators to measure human health: 
FS.I.HH.J - Number of confirmed cases of zoonosis from disease j (j=Salmonella, 
Brucellosis, …).   
In addition to this, a measure of quality of life can also be included, such as:  
FS.I.QALY - QALY (Quality Adjusted Life Years): this is a measure of health outcome 
(morbidity) that considers the reduction in quality of life due to illnesses. It is a 
composite indicator that can be computed for all kind of illnesses and can be used to 
compare different levels of health quality in different countries. 
FS.I.DALY - DALY (Disability Adjusted Life Years): this is computed as the sum of the years 
of potential life lost due to premature mortality and the years of productive life lost due 
to disability.  
                                           
22 On the one hand, supply might change due to fluctuations in the exchange rates, temporary trade restrictions 
or changes in input prices. On the other hand, demand might be affected by changes in tastes and 
preferences, population growth, responses to food safety issues, income growth, changes in the price of 
other substitution goods. 
23 The potential sources of information on trade are the following. 1) Trade Market Access data and Statistics 
(EU Commission) that contains detailed trade information between EU and non-EU countries such as the 
monetary value and the quantity of export and import of live animal, animal products and vegetable 
products. 2) EUROSTAT COMEXT within EU trade dataset that contains detailed information about within-
EU trade such as the monetary value and the quantity of export and import of live animal, animal products 
and vegetable products. 3) DG AGRI dataset contains detailed product data by country (e.g. dairy herds 
and yields, milk production).  
24 World Health Organisation (2015) WHO estimates of the global burden of foodborne diseases: foodborne 
diseases burden epidemiology, reference group 2007-2015 
(http://www.who.int/foodsafety/publications/foodborne_disease/fergreport/en/). 
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Box 3: Indicators to measure effectiveness in plant and animal health, and official controls 
 
Three types of effectiveness indicators can be used in the evaluation: 
— Output and result indicators that measure the outcomes that are directly related to 
the interventions  
— Impact indicators are relevant indirect economic and/or social outcomes induced by 
the interventions 
Which indicators to use depend on: 
— the study question 
— the stage of the policy cycle that needs to be evaluated; before, during or after the 
implementation of the intervention 
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4 Cost-effectiveness analysis without experimental setting: 
Identifying the causal impact of the intervention 
 
4.1  The Evaluation Framework: definitions 
4.1.1 Types of cost-effectiveness ratios based on the intervention design 
 
CEA is a methodology that performs a comparative analysis between two or more types 
of interventions, in which both costs (cost evaluation) and impacts (impact evaluation) 
are compared. In the context of the CFF spending the impacts, i.e. effectiveness of the 
interventions are measured either by the output, result or impact indicators discussed in 
section 3.1. As discussed, the indicators should be positioning in the policy cycle. The 
cost measures depend on the perspective of the analysis as discussed in section 2.1. 
In section 1.4.3 the basic notions on CEA were presented in a general set up. This 
section discusses how to conduct CEA analysis in the context of the evaluation of the 
spending on the food chain area. In particular different types of Cost Effectiveness Ratios 
are suggested that are specific to the context of the intervention or to the type of 
evaluation to be performed. These can be interpreted as special cases of the ICER and 
vary according to the nature of the alternative intervention. 
In this context, the term alternative intervention must in this context be given a broader 
interpretation beyond the typical set-up where there are two or more mutually exclusive 
interventions. In the context of the CFF spending it will be of interest to consider three 
types of alternatives interventions: (i) inexistent –arising whenever a new type of 
intervention is implemented with a new set of targets; (ii) qualitatively different but with 
the same target or; (iii) qualitatively similar but with a different degree of (spending) 
intensity.  
The choice of the relevant CER will depend on the nature of the alternative intervention 
but also on the policy evaluation question of interest. A CER could be computed to simply 
address the (average) cost performance of a single intervention, assess the effectiveness 
of varying the intensity of a given intervention, or to evaluate how new policy 
instruments are cost effective to complement existent interventions. These approaches 
are not mutually exclusive and for some spending areas it might be relevant to compute 
more than one type of CER. 
Given relevant measures of the cost and effectiveness of an intervention the following 
cost-effectiveness ratios (CER) can be computed. 
4.1.1.1 Incremental cost-effectiveness ratio (ICER)  
As discussed in section 1.4.3, the ICER is computed as the ratio of the difference in the 
cost of the two interventions and in their effects.  
# &*	 )!*	(( *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The ICER gives the extra cost per extra unit of effect and can be used as a decision rule 
in resource allocation. When compared to a pre-determined threshold for the willingness 
to pay (WTP) (for intervention B) it allows deciding if choosing the new intervention is an 
efficient use of resources. If for a given intervention the ICER is above this threshold it 
will be deemed too expensive and thus should not be funded, whereas if the ICER lies 
below the threshold the intervention can be judged cost-effective. 
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4.1.1.2 Marginal cost-effectiveness ratio (MCER) 
The Marginal Cost-Effectiveness Ratio (MCER) is the appropriate CER whenever the 
alternative intervention only differs with respect to its intensity, i.e. as the intervention 
expands or reduces. It is therefore computed as special case of the ICER since the 
interventions only differ with respect to its cost. 
 
01	 )!*	(( *!!	*)	(0,) =
 ℎ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While the MCER can assesses the cost-effectiveness of the same intervention with 
different intensity, the ICER compares two interventions with the same target. Therefore 
the MCER can provide guidance when the aim is to assess the optimal level of 
implementation, i.e., the level of intensity of the intervention where most effects are 
reached at lowest cost. 
4.1.1.3 Average cost-effectiveness ratio (ACER) 
The Average cost-effectiveness ratio (ACER) is the ratio of the cost to the effectiveness of 
an intervention without reference to a comparator25. If an output indicator is used as an 
effectiveness measure the ACER is just the average cost of the intervention. The ACER 
corresponds to the ICER when the alternative intervention is inexistent:  
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Computing the ACER is therefore the appropriate measure of CE upon the introduction of 
an intervention with respect to which there are not and there have been no interventions 
with the same target. 
From the policy decision making point of view the ACER can be used to devise a decision 
rule based on a fixed budget in order to maximise total effectiveness. 
4.1.2 Causation and the identification problem 
In order for an evaluation to be accurate and to allow solid policy indications, one needs 
to identify a causal relationship between the explanatory variables and the outcomes 
under examination. For instance, in the case of the evaluation of a programme for the 
eradication of Bovine Tuberculosis, the causal effect of the explanatory variable “money 
invested in the programme” on the outcome “eradication rate” would identify to what 
extent the occurrence of the programme determines an increase in the eradication rate.  
The first challenge in identifying causality, is its distinction from correlation. Correlation 
is a measure that describes the direction and the size of a relationship between two or 
more variables. In other words, when two or more variables are correlated they can 
display a similar (or opposite) behaviour. If the variables increase or decrease altogether, 
the variables are said to be positively correlated. Vice versa, if one increases and the 
other one decreases the correlation is negative. In both cases, however, the correlation 
between two variables does not imply a causal relationship between them, i.e. that the 
change in one variable causes a change in the other variable.  
In practice, it is possible to pinpoint a causal relationship between two variables by 
solving the so-called identification problem. This consists in determining the best 
estimate of the value of a given parameter in a regression, net of all possible 
confounding factors (contextual indicators that may influence the effect under analysis in 
                                           
25 In section 1.4.3 the ACER was referred to as “cost effectiveness description”. 
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such a way that the estimated results do not reflect the true relationship). For example, 
the incidence of Salmonellosis infections in animals and in humans are positively 
correlated (i.e. the more infections in animals, the higher the incidence among humans). 
Nevertheless, the causal effect of a high incidence rate of Salmonellosis in animals on the 
number of infections in humans can be identified only if one takes into account 
confounding factors that are known to be related to the incidence of the disease, such as 
hygienic conditions, eating behaviours and average temperatures.  
The identification problem is often generated by the lack of (good-quality) data. This 
may be due to small sample size and/or to the complete or partial absence of certain 
measures that are thought to have a role in the process under scrutiny. In fact, 
sometimes even relatively little absent information on some variables can yield a 
substantial reduction in the sample size. Given that most statistical methods rely on the 
assumption of having a sufficiently large number of observations, this may result in a 
loss of precision in the estimated parameters of interest. Furthermore, when all or some 
information on specific variables which are thought to be relevant for the analysis are 
missing, it may become impossible to disentangle the causal effect of the intervention. It 
may be the case, for instance, that one wants to evaluate the causal effect of an 
emergency measure aimed at eradicating an outbreak of Xylella fastidiosa and that, at 
the same time, private investments are thought to be confounding this relationship. If 
there is lack of information on the investments made by farmers, then the identification 
of the effect of the measure on the outbreak of Xylella becomes arduous. These issues 
are amplified when the confounders that are thought to affect the relationship between 
the exposure to intervention and outcome are hardly measurable, like in the case of 
unobservable characteristics (e.g. effort put by the farmer). 
 
4.1.3 Counterfactual impact evaluation (CIE) 
In this specific context, impact evaluation is useful for finding evidence on whether a 
specific EU policy induced the intended changes in the target group’s outcome (for 
instance, the effect of National veterinary programmes on eradication outcomes), or 
whether it had no impact, or even had unintended positive or negative consequences. 
In practice, impact evaluation aims at answering the following counterfactual question: 
what would have happened to the target group affected by a given policy in case the 
policy had not been implemented? The average difference in the outcome (result, impact) 
indicator induced by the intervention is called the Average Treatment Effect (ATE). 
Impact evaluations that analyse counterfactual questions are called Counterfactual 
Impact Evaluations (CIE). They embody the standard methodologies in policy evaluation 
where the contribution of a given programme to the outcome variables is assessed by an 
ex-post impact evaluation analysis. Typically, this requires statistical handling of micro-
data, or individual-level data. This is intended to be collected at the level of the unit 
(individual) that is targeted by the policy, e.g. animals, farms or regions/municipalities, 
so that the more detailed, complete and disaggregated the data, the more accurate is the 
analysis. 
The characteristics of the target group that are relevant for a policy impact evaluation 
are called outcome variables (result and impact indicators). These may consist in either 
intended or unintended effects of the policy. Examples of outcome variables include: 
incidence rate, number of outbreaks, number of successful eradications of pests, 
production losses, value of live animals traded, and price of meat. Moreover, any 
evaluation should take into account all potential external elements (i.e. confounding 
factors) that might have an effect on the selected outcome variables. This is crucial to 
ensure a reliable evaluation that accurately isolates the effect of a policy, which, in turn, 
allows determining the EU’s added value correctly. 
At first glance, in fact, the solution to the counterfactual questions might rely on the so-
called naïve before-after comparison. This consists in computing the difference between 
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the selected outcome variables before and after the policy implementation. As an 
example, one could consider comparing the number of positive test results before and 
after some specific veterinary programmes are introduced in a given country. Hence, a 
decrease in the average number of positive test results, say by 3 percentage points, 
might lead to the conclusion that such a decrease is entirely due to the EU National 
veterinary programme. However, such conclusions might be imprecise (hence, the name 
“naïve”) because they do not account for other factors that might have contributed to the 
difference in the said outcomes, such as other measures funded by the local government 
or the natural decreasing trend of the disease due to biological or weather factors. 
Therefore, a more appropriate methodology should be chosen in order to achieve a better 
estimation of the effects of an intervention.  
The main challenge in the counterfactual evaluation setting is that only one state of the 
world is actually observed. In other words, when evaluating the effects of an 
intervention, typically one can directly observe its consequences but not their 
counterfactual (what would have happened in the absence of the intervention). Since the 
impact of the intervention is assessed by comparing the two settings, it is necessary to 
find an approximation of the counterfactual. Most CIE methods rely on the existence of 
two comparable groups of individuals or units of observation (e.g. animals, farms, etc.): 
the treated group, which is the one receiving the intervention and the untreated or 
control or placebo group, which is made of individuals who do not receive the treatment.  
In principle, for counterfactual analysis to be valid, the two groups should be perfectly 
identical except for the application of the intervention (i.e. the treatment). Hence, for 
each evaluation analysis it is essential to be able to define and identify the appropriate 
control group.  
A thorough description of the indicators is provided in section 3, while an account of the 
challenges related to data acquisition and to the identification of the control group can be 
found in the next section. What follows provides a brief description of the most common 
CIE methods. A priori, no method is superior to another in absolute terms. The optimal 
evaluation method must be chosen on the basis of the type and structure of the available 
data and the specific characteristics of the policy intervention that needs to be assessed. 
In all cases, the final goal is to identify the causal effect of a specific intervention with 
accuracy and precision.  
4.1.3.1 Randomised control trials (RCT) 
Randomised control trials (RCT) consist in experimental settings where two groups of 
individuals or units of observation (e.g. animals, farms, etc.) are defined: the treated and 
the control. The main feature of the RCT setting is that all individuals are randomly 
allocated to either group. The randomisation should be such that it generates two 
identical groups which differ only in the fact of receiving the treatment. This strategy is 
crucial for the identification of the causal effect of the treatment, which is found by 
simply comparing the average outcome of the two groups. This could be used in cases 
where, for instance, farms that can benefit from an intervention (treatment) in a given 
area are chosen through a random draft. In such a setting, however, it is important to 
rule out any potential externality effect, that is the possibility that the presence of a 
treated farm has a positive influence on the outcome of the neighbouring (untreated) 
holdings and vice versa. 
While it is frequently used in medicine, RTC is not easily implementable in policy 
evaluation because, by nature, it requires the existence of a very specific setting. Yet, 
when properly designed, this method is extremely convenient in terms of computation of 
the results because it yields a clear identification of the effect under analysis: any 
difference between the treatment and the control group must be due to the treatment. 
Unfortunately, in many instances, the results of a RTC analysis have little external 
validity, i.e. they cannot be generalised outside of the context where they are generated. 
Nevertheless, to a certain extent, predictions can be usually made about what the effects 
of related programs in similar contexts could be. 
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4.1.3.2 Difference-in-differences (DiD) 
The identification of a causal relationship can be reached with the implementation of the 
Difference-in-differences (DiD) method. Again, this requires the definition of two groups 
of individuals or units of observation: the treated group and the untreated or control 
group. The existence of the control group ensures to isolate the counterfactual situation 
of what would have happened to the treated group in the absence of the policy. Because 
of this, the control group should be as similar as possible to the treated group. A 
plausible setting in which the DiD method can be applied is one where all farms in a 
region are exposed to an intervention (treated group) and none of the farms in a similar 
region receive the said intervention (control group).  
The DiD consists in taking the difference in the outcomes between the two groups after 
the policy implementation (say period t+1), the difference before the policy 
implementation (say period t), and finally the difference between the two differences 
(difference-in-differences). The DiD method can also be implemented in regression form, 
including potential confounders in the regression.  
The advantage of this method crucially hinges on the assumption that the control group 
is a good counterfactual of what would have happened to the treated group in the 
absence of the policy. This can be checked by verifying that the two groups were 
behaving similarly before the implementation of the intervention (sometimes called the 
“parallel trends” assumption). Specifically, in the absence of the treatment, both treated 
and control groups would have experienced over time the same trend in the outcome 
variable. Therefore, any deviation from the trend observed in the treated group can be 
interpreted as the effect of the treatment. In order to verify the parallel trends 
assumption it is important to have information on the two groups in the periods before 
the implementation of the intervention. 
4.1.3.3 Regression discontinuity design (RDD) 
Similarly to the DiD, the regression discontinuity design (RDD) method requires the 
identification of a treated and a control group. In this case the eligibility to the policy has 
to be defined according to a quantitative variable for which a threshold is set. This could 
be, for instance, the case in which additional funds are given to farms to replace the 
animals that have been slaughtered following an epidemic and that such funds are 
granted only to farms that have lost at least a given percentage of their animal livestock 
(say, 50%). 
The RDD consists in focusing solely on the two groups that are close to the eligibility 
threshold. In the previous example, one would evaluate the replacement intervention 
around the 50% level, by comparing the farms that are just above and just below the 
threshold (e.g. above 45 and below 55), under the assumption that the two groups of 
farms are identical in all aspects but receiving the intervention.  
The RDD method can be implemented in regression form. The main issue with this 
methodology is that it only allows estimating the causal effect of a policy on the outcome 
for the groups around the threshold but it makes it difficult to infer the results to other 
groups further away from the same threshold, i.e. the analysis has internal validity but 
may lack of external validity. In the previous example, this may happen if, e.g., as soon 
as the ratio of sick animals over the total livestock reaches a certain level (say 70%), 
farmers find it more profitable to shut down their activity or to switch to other types of 
farming. 
4.1.3.4 Matching 
Matching is also a method that requires the definition of treatment and control groups 
and where the effect of the treatment is computed by comparing the individuals across 
the two groups. Specifically, each individual in the treated group is “matched” to one or 
more counterparts in the control group on the basis of all observable characteristics. 
Then, a comparison between the outcomes of the treated and the non-treated yields an 
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estimation of the effect of the treatment, where the bias due to the confounders is 
reduced thanks to the matching process. Clearly, the accuracy of the matching is strictly 
dependent on the richness of information on the observable characteristics: the more 
exhaustive the list of variables, the better the matching, and the more precise the 
computation of the effect. 
 
4.2 Specific evaluation challenges in non-experimental settings 
 
Impact evaluation and measuring the cost-effectiveness of an intervention require the 
existence of a clear evaluation plan and precise measurements. In order to achieve this, 
it is important to deal with the following potential issues which might threaten the 
validity of the analysis. 
4.2.1 Informative harmonised database 
With respect to measurements, it is essential to ensure the existence of a complete, 
detailed and harmonised database. This should include information on all observable 
characteristics of the unit of analysis and of the environment in which the said unit 
stands. For instance, if one uses farms or holdings as unit of analysis, then it becomes 
necessary to have information on the features of the farm: its size (number and type of 
plants or animals farmed, number of employees, whether there is uninterrupted access 
to clean water, etc.), the type of farming techniques and the level of technology 
employed (e.g. the value of the machinery), whether the farmer has access to public or 
private funding and the amount of each transfer, history of diseases and pests detected 
and/or treated by the farmer. Furthermore, in order to account for external confounding 
factors, it is also important to have information about the geographical area in which the 
farm is located, including average GDP, whether the area belongs to any special funding 
intervention (e.g. “Objective One” regions), prevalence of farming types, type, incidence 
and timing of diseases and pests in the area, etc. One aspect that is especially relevant in 
this context consists of clearly isolating the effects of a given EU-funded intervention 
from those of other interventions that might be funded by the single Member States or 
co-funded with the EU itself. Hence, a clear distinction between the various sources of 
funding is essential.  
As reported in previous documents by the European Commission, the epidemiological 
data provided by the individual operators and the Member States appear to be reliable 
and consistent with data from other sources.26 Nevertheless, access to micro-data is 
sometimes problematic, especially at the most disaggregated geographical level, such as 
farm orholding level. Hence, all efforts should be made to guarantee access to 
administrative data in order be able to evaluate the impact and the effectiveness of the 
interventions in the food chain area. 
4.2.2 Identification 
As regards the identification of a clear setting, in many cases this is the most challenging 
task of all. As stressed in the previous sections, in fact, counterfactual evaluation analysis 
aims at assessing the effects of a given treatment (the implementation of a given 
intervention) on the treated unit of observation and, by definition; it requires the 
existence of a control unit or group. The control stands for an equivalent situation to the 
one under study (treated) such that the only difference between them is the treatment 
itself. An inappropriate choice of the control can seriously jeopardize the validity of the 
                                           
26 “Evaluation of the Eradication, Monitoring and Control Programmes for Animal Diseases, Final Report 2013.” 
Directorate-General for Health and Consumers and ICF GHK. 
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analysis. Hence, the identification of the control must be tailored on the specific setting 
that is under study and only general issues can be addressed at this stage. 
4.2.3 Confounding factors 
Within the counterfactual evaluation framework, the following issues are likely to occur 
and must be dealt with. First, as mentioned, external confounding factors can have an 
impact on both the exposure to the intervention and the outcomes, so they might alter 
the estimated effect of an intervention. The same occurs in the case of selection. Here, 
the exposure to the intervention depends on unobserved features which, in turn, affect 
the outcome. A very common example pertains to individuals or communities that are 
chosen to participate to a policy intervention because they are more likely to benefit from 
it. In this case, the `true’ estimated effect of the intervention should be taking into 
account the selection bias, i.e. that the treated group has a higher propensity to benefit 
from it compared to any other group, regardless of the intervention itself. Then, 
spillovers and contamination might also arise. In the first case, the control group is also 
affected by the intervention, making it hard to isolate the exact causal effect of the 
intervention. In the latter, the treated and/or the control groups have access to another 
intervention that has an effect on the outcome, so that a clear distinction between the 
effects of the two different interventions should be made. 
4.2.4 Selection bias 
Generally speaking, any analysis aimed at identifying the causal effect of an intervention 
on the outcome should account for all the potential sources of bias generated by these 
circumstances. In the specific context of eradication, monitoring and control programmes 
in the food chain area, some additional issues appear to be potentially relevant.  
First of all, some programmes, such as the survey programmes for plant health, are 
bound to reach full coverage of the EU territories and lead to universal implementation. 
The same happens in the case of emergency measures for eradication and containment, 
which are put into place as soon as an eligible pest or disease is detected within any EU 
MS. In terms of counterfactual analysis, this implies that all areas would be defined as 
treated and identifying the control group in this setting can become problematic.  
One solution to this relies on geographical comparisons and might be found in the use of 
non-EU units of observation as control group. They may be either extra-EU territories or 
pre-EU accession regions, provided that they are similar to the treated units under 
analysis in terms of economic and environmental features (i.e. they are comparable).   
Another variation that can be used refers to timing. Specifically, the control group can be 
identified in those instances in which the application of the intervention is not 
contemporaneous in all areas. If country A implements the intervention in year t and 
country B complies in year t+2, then this difference in timing can be exploited such that 
one can identify a control group within the two years in which country B was not 
implementing the intervention but country A was. 
A third option could be a comparison across harmful organisms that have similar 
epidemiological characteristics but of which one is covered by the EU funded intervention 
and the other one is not. This would be the case of, e.g., disease A and disease B, both 
of which have similar contagion patterns and similar symptoms on animals and/or plants 
but only disease A enters the eligibility criteria for a given eradication and control 
programme to be funded. Hence, the question of “what would have happened in the 
absence of the programme” can be addresses by comparing the outbreaks of the two 
diseases. 
4.2.5 Heterogeneity across MS 
Moreover, when it comes to the implementation of eradication, monitoring and control 
programmes, some evidence of both structural and organisational difficulties for the MS 
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arises. These lead to a sub-optimal implementation of the interventions and lower 
effectiveness in terms of outcomes.  
Structural issues relate mainly to the nature of some farming practices (e.g. the 
widespread existence of backyard holdings in some countries makes it hard to identify 
the holdings themselves and to count animals and plants therein), to the fact that 
diseases may pass into a country from a neighbouring one, particularly in areas that act 
as the EU’s external border, and to the presence of wildlife reservoirs, which might 
foment the transmission of diseases by re-infection or even by spreading them in areas 
that had not been previously affected. 
Organisational issues, on the other hand, may be due to various reasons. One of them is 
the low-quality co-ordination between and within Member States. On the one hand, poor 
or absent co-operation between neighbouring countries is detrimental because it causes 
an increase in the costs of the intervention. This is particularly important in countries that 
experience high incidence of diseases that are spread by the wildlife, such as the recent 
cases of rabies in Bulgaria and Romania, and even more so in areas that are at the EU’s 
external border. On the other hand, the lack of co-ordination and co-operation within a 
single country can also be a problem because it leads to increases in costs and loss in 
operational efficiency.  
Other reasons may be linked to the lack of systematic gathering of information 
(databases) or to differences in standards across countries. For instance, differently from 
the rest of the EU, in Ireland and the UK by law a holding does not need to encompass 
only contiguous land, but it can include all the land that is managed by the same keeper, 
regardless of its specific location. Such lack of distinction between contiguous and non-
contiguous land, as a consequence, has caused delays and difficulties in the 
implementation of disease eradication programmes.  
Other organisational issues may be related to delays in payment or in the delivery of the 
appropriate equipment, which might, in turn, compromise previous efforts to achieve the 
desired outcome and lead to a failure of the intervention. Finally, in some cases, the 
design of the programme did not take into account an appropriate set of incentives for 
farmers, whose co-operation in transmitting accurate and detailed information and in 
complying with the procedures set by the competent authorities is crucial for the 
effective implementation of measures. 
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Box 4: Identification of the causal impact of the intervention 
The main challenge for identifying the causal impact of an intervention is to be able to 
measure what would have happen in the absence of the intervention under evaluation. 
This counterfactual situation is by definition not observable as regions or MS are either 
receiving the interventions or not. The aim of policy evaluation methods (or CIE 
methods) is to find the best proxy possible to measure the counterfactual situation i.e. to 
find a so-called “control group”. 
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5 Measuring Cost-effectiveness in the Food chain area 
 
Based on the concepts introduced in the previous chapters regarding the measurement of 
costs and effectiveness, and what would have happened in the absence of the 
intervention, this section presents the three main methodological points to consider in 
order to perform a cost-effectiveness analysis in the food chain area; (i) which 
identification strategy(ies) to implement, (ii) which estimation method(s) to run and  (iii) 
which cost-effectiveness indicators to use. 
5.1 Identification strategies 
 
This section discusses the appropriate strategy to identify the effectiveness of the EU co-
funding in the food chain area. Two possible solutions are envisaged depending on 
whether a control group can be identified with which a counterfactual analysis can be 
performed..  
5.1.1 The existence of a control group 
 
The possibilities of finding a control group within the food chain area are discussed in the 
following subsections differentiating planned programmes from emergency measures. 
5.1.1.1 Planned programmes 
 
Planned programmes such as eradication, control or surveillance programmes in animal 
health or survey programmes in plant health are in general tailored fitted to Member 
States’ needs (via working programmes). 
In this case, possible control groups could be: 
1. EU regions receiving no funding either because; (i) MS that applied for funding 
but their submitted programme was rejected or; (ii) MS that did not apply while 
being at risk. 
2. Regions in other countries such as EU candidates may also be used as control 
groups. 
3. Regions which implement the policy later than the treated region. 
If potential control groups exist they need to be similar to the treatment group that is the 
population or the region receiving the intervention under evaluation.  
5.1.1.2  Emergency measures 
 
In the case of emergency measures, identifying a good control group to evaluate what 
would have happen if the MS would not receive EU funding is even harder because all MS 
are required by the EU legislation to take measures in the presence of an outbreak. 
 
5.1.2 The entire target population receives the intervention  
 
One can assume that the entire target population receives the intervention when the risk 
assessment is properly done for each population/region so that the entire target 
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population is defined and the funds are awarded to all risk groups previously defined 
which is the population of interest (As defined under the CFF regulation)27. 
In this case, it is relevant to note that there is no selection bias as all the target 
population receives the intervention. However, measuring the cost-effectiveness of an 
intervention compared to no intervention is not feasible. 
Nevertheless, a cost-effectiveness analysis can be performed to evaluate the marginal 
(increase in funding over time) and/or the incremental (change in the intervention 
measure) cost effectiveness of an intervention compared to the same intervention before 
the qualitative or quantitative change in the intervention.  
 
5.2 Econometric based analysis28 
 
This section describes a general econometric methodology to perform CEA. Given the 
availability of data at the region/MS level over time regression methods are the 
appropriate methodologies to perform economic evaluation. Regression methods allow 
addressing the important issue of confounding factors and selection issues in order to 
correctly assess the impact of EU co-funding on the outcomes of interest. In particular in 
the context of cost-effectiveness analysis the Net Benefit Regression approach provides a 
solution for the challenges posed by the computation of CER and namely the ICER. 
 
To compute the ICER, one can then estimate the following regressions: 
)!*3 = 45 + 4783 + 39 + :3, 
(( *!!3 = ;5 + ;783 + 39 + :3, 
using data on the units i over a period of time t=1, …, T where 
)!*3 and (( *!!3are the chosen measures of cost and effectiveness 
for each unit i and t.  
8<= =1 for a new intervention at time t in unit i, 8<= = 0 otherwise; 
:3 =	the random error term for unit i in period t; 
3 =	the set of regressors for unit i in period t; 
 
The treatment variable 8<= embeds the nature of the intervention. It incorporates all 
changes in the intervention that occurred in the time interval considered for observation 
unit i29. It can be associated with the introduction of a new measure or just with a 
change in the intensity of an existing intervention.30 
These equations can be computed by a difference in group means under each treatment. 
However, since simple average does not allow considering other factors that influence the 
effectiveness of the intervention that may differ across units (regions/MS) nor the 
potential selection bias when the entire target population does not receive the 
intervention, a regression approach provides a way to estimate directly the average 
difference in cost and the average difference in effectiveness while controlling for 
                                           
27 However, as mentioned in section 5.1, one could only identify a control group if MSs would not have applied 
or the risk assessment was not correctly or if the EU did not recognized the MS at risks. 
28 An application of this econometric method is provided in Box 7 of Chapter 7. 
29 This would be the case when different region or MS start implementing a co-funding intervention in different 
years. 
30 Here two alternatives are compared but the method could be extended to more than two 
measures/activities/programmes to be compared. 
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confounding factors (3) and potential selection bias using CIE methods as discussed in 
chapter 4. 
 
The ICER is then of the form: 
ICER =
∆
∆
=
41
;1
 
 
As discussed in chapter 1, the ICER needs to be compared to the WTP. An appropriate 
way of estimating the cost-effectiveness is to use the Net Monetary Benefit as follows: 
NBE = WTP ∗ EE − CE 
The WTP can be viewed as the conversion factor allowing cost and effect to be valued in 
the same units. 
As the ICER which is a ratio that allows comparison of two interventions, the Incremental 
Net Benefit (INB) is defined as the monetary difference between the net benefits: 
#I. = J8K ∗ . − . − (J8K ∗ / − /) = J8K ∗ ∆ − ∆  
The second equality makes evident the relation between the ICER, the WTP and the INB.  
The net benefit regression (NBR) using data on the units i over a period of time t=1, …, T 
and assuming a choice for the value of WTP is of the form:  
'<= = L5 + L783 + 39 + :3 
'<= = the net benefit for observation unit i in period t; 
The estimate of the expected INB in the population is the coefficient L7. If L7 > 0, the new 
intervention is cost-effective for the given value of WTP. The procedure relies on 
estimating the net benefit regression for several values of the WTP.  
Using the NBR to estimate the cost-effectiveness has several advantages over computing 
the cost-effectiveness ratio; first it is possible to test the sensitivity of the cost-
effectiveness conclusion to the value of the WTP computing the probability of the new 
intervention to be cost-effective for different values of WTP and displays the cost-
effectiveness acceptability curve (CEAC). 
This equation is a general form including only confounding factors and the interventions 
to be evaluated (T). This form is valid only when the entire target population receives the 
intervention as in this context no selection issues arise.  
When not the entire target population receives the treatment this equation needs to be 
extended with one suitable CIE method presented in chapter 4 to account for potential 
selection bias and to allow for identifying the causal effect of the intervention. 
5.3 Cost-effectiveness indicators for the Food Chain Area 
 
This section provides a set of cost-effectiveness indicators (CEI) based on the indicators 
proposed in chapter 3 to measure the effectiveness of the interventions. In principle, CEI 
can be computed on the basis of all Effectiveness Indicators. Also they can be based on 
Output, Result and Impact depending at which stage of implementation of the 
intervention one wants to measure the cost-effectiveness. 
• Output CEI are a measure of average costs that might be relevant in terms of ex-
post analysis of the CFF budget allocation without looking at the results. They can 
be used as monitoring indicators to assess how well the implementation of the 
intervention is going. They can be computed as Average Cost-Effectiveness 
Ratios.  
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For instance, the average cost per survey actions implemented (Survey programme in 
Plant Health) can be computed as: 
/1	 )!*	(( *!!	*)	(/,) =
8)*	 )!*	)(	!	 *)!	&&*$		
I&'	)(	!	 *)!	&&*$
 
 
• CEI based on Result and Impact Indicators are used to measure the ex-post cost-
effectiveness of the intervention. They are computed thanks to the identification 
strategies presented in section 5.1 and the estimation method described in section 
5.2.  
The Result and Impact CEIs in addition to their link to the objectives of the programme 
were chosen based on31: 
- Their degree of applicability in different settings. This criterion 
means that the same indicator can be collected and computed for all 
MS and regions in a uniform way. But also its ability to be computed 
at different levels of aggregation (in terms of geographical 
information, time or type of diseases.) 
- Data availability. Use of data already collected in the food chain 
area also through other sources. Potential sources of data are 
discussed in chapter 6. 
- Burden of data collection: This criterion should be assessed when 
planning the evaluation and will be covered in chapter 6.  
For each intervention in the three spending areas i.e. Plant Health, Animal Health, and 
Official Controls; one Output, two to three Result and Impact CEIs for use in CEA in the 
Food chain area (Tables 7, 8, and 9) are proposed. 
The feature of the selected CEIs is that they can be computed at different level of 
aggregation (local areas, regions, MS, by disease or types of disease, for a whole 
programme, by lab in the area of official controls) 
The impact will always be with respect to the impact indicator that measures reduction in 
production losses both in volume and value because it is relevant in all activities under 
animal and plant health. Other impact indicators could be suggested such as the 
reduction in net exports or investment but may be only applicable to a class of activities 
where export matters and investment is continuous. 
                                           
31 Those criteria are based on some of the criteria for selection of indicators developed for instance by EvaluATE 
http://www.evalu-ate.org/authors/goldie-macdonald/ in a Checklist to Inform Monitoring and Evaluation. 
http://www.wmich.edu/sites/default/files/attachments/u350/2014/Indicator_checklist.pdf 
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Table 7: Selected cost-effectiveness indicators in Plant health 
 
 Survey programmes Emergency measures 
Eradication Containment 
CEI 1 
(OI) 
Cost per survey actions 
implemented 
Cost per 
eradication 
measure put in 
place 
Cost per containment 
measure put in place 
CEI 2 
(RI) 
Cost per HO/pest 
detected 
Cost per 
successful 
eradication 
measure 
Cost per successful 
containment measure  
CEI 3 
(RI) 
Cost per early action 
taken 
Cost per 
reduction of time 
to eradicate 
pest/outbreak 
Cost per reduction of time 
to contain pest/outbreak 
CEI 4 
(RI) 
Cost per outbreak of 
pests covered by EU 
legislation avoided 
Cost per outbreak of 
pests covered by EU 
legislation avoided due 
to early action taken  
  
CEI 5 
(II) 
Cost per production loss 
due to pest detected / 
outbreak 
Cost per 
production loss 
due to pest 
detected/outbrea
k 
Cost per production loss 
due to pest detected / 
outbreak 
CEI 6 
(II) 
Cost per unit of 
gain/reduction in (net) 
export 
Cost per unit of 
gain/reduction in 
(net) export 
Cost per unit of 
gain/reduction in (net) 
export 
Cost-Effectiveness Indicator (CEI), Output Indicator (OI), Result Indicator (RI), Impact 
Indicator (II) 
Table 8: Selected cost-effectiveness indicators in Animal health 
 Veterinary programmes Emergency 
measures 
Eradication Control Surveillance  
CEI 1 
(OI) 
Cost per 
eradication 
programme  
Cost per 
control 
programme 
Cost per 
surveillance 
programme 
Cost per 
emergency 
measure 
CEI 2 
(RI) 
Cost per 
MS/region free 
from disease 
Cost per 
target 
achieved (for 
disease j) 
Cost per target 
achieved (for 
disease j) 
Cost per 
successful 
emergency 
measure 
CEI 3 
(RI) 
 Cost per 
target 
achieved 
(aggregated 
for all 
disease) 
Cost per target 
achieved 
(aggregated 
for all disease) 
Cost per 
outbreak 
avoided 
Cost per 
secondary 
outbreak 
avoided 
CEI 4 
(II) 
Cost per 
gain/reduction 
in 
production/pro
ductivity 
Cost per 
gain/reductio
n in 
production/pr
oductivity  
Cost per 
gain/reduction 
in 
production/pro
ductivity 
Cost per 
gain/reduction 
in 
production/pro
ductivity 
CEI 5 
(II) 
Cost per unit 
of 
gain/reduction 
in (net) export 
Cost per unit 
of 
gain/reductio
n in (net) 
export 
Cost per unit 
of 
gain/reduction 
in (net) export  
Cost per unit 
of 
gain/reduction 
in (net) export 
CEI 6 
(II) 
Cost per case 
of zoonosis 
avoided 
Cost per case 
of zoonosis 
avoided 
Cost per case 
of zoonosis 
avoided 
Cost per case 
of zoonosis 
avoided  
Cost-Effectiveness Indicator (CEI), Output Indicator (OI), Result Indicator (RI), Impact 
Indicator (II) 
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Table 9: Selected cost-effectiveness indicators in Official controls 
 Better Training for Safer Food EU reference laboratories 
Workshops e-learning Sustained 
training 
missions 
(STM) 
Proficiency 
tests (PT) 
EURL 
Workshops 
CEI 1 
(OI) 
Cost per 
workshop 
participant 
Cost per e-
learning 
training 
participant 
Cost per STM 
participant 
Cost per PT (by 
lab type) 
Cost per 
workshop 
participant 
CEI 2 
(RI) 
Cost per increase 
in test score  
Cost per 
increase in 
test score  
Cost per 
increase in test 
score  
Cost per 
increase in 
successful PT 
Cost per 
increase in test 
score 
CEI 3 
(RI) 
Cost per increase 
in percentage 
point of 
satisfaction rate 
Cost per 
increase in 
percentage 
point of 
satisfaction 
rate 
Cost per 
increase in 
percentage 
point of 
satisfaction 
rate 
Cost per 
increase in 
percentage 
point of 
satisfaction 
rate  
Cost per 
increase in 
percentage 
point of 
satisfaction 
rate 
Cost-Effectiveness Indicator (CEI), Output Indicator (OI), Result Indicator (RI). 
 
 
Box 5: Cost-effectiveness estimation strategy 
When setting the estimation strategy to perform a cost-effectiveness analysis in the food 
chain area, the following points needs to be discussed: 
— The identification strategy 
— The estimation methods 
— The cost-effectiveness indicators 
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6 Implementation requirements  
 
The methodology described in this report to measure the impact and the cost- 
effectiveness of the interventions funded under the food chain area is an in-depth-data-
driven technique. This technique is grounded on micro data and provides robust ex-post 
evidence on the impact and the efficiency of interventions. The method requires careful 
planning of the monitoring and evaluation of the interventions. 
This chapter provides guidance on data collection and requirements, and evaluation 
planning which are key for applying this methodology.  
 
6.1 Planning the evaluation 
6.1.1 Legal deadline for the ex-post evaluation of the interventions 
implemented within the Food chain area 
 
In September 2017 the Commission established and presented (to the European 
Parliament and to the Council) a mid-term evaluation report on whether, in terms of their 
results and impacts, the interventions funded under the common financial framework of 
the food chain area (CFF, Regulation (EU) No 652/2014) achieve their objectives. 
Under article 42 (“Evaluation”) of the CCF Regulation itself, the Commission shall carry 
out an ex-post evaluation of the measures referred to in paragraph 1 of this Article in 
close cooperation with the Member States by 30 June 2022. This ex-post evaluation shall 
examine the effectiveness and efficiency of the funded interventions and their impacts. 
The main objective of this report is to serve as a guidance document to help the 
responsible authorities to carry out the ex-post evaluation referred above. It also 
provides the MS with the tools tailored to their needs to prepare the annual technical and 
financial report that each MS receiving funding shall submit by 30 April each year at the 
latest (Art. 14 of Regulation (EU) No 652/2014). 
 
6.1.2  Evaluation plan 
 
Good evaluation planning is a critical step to ensure the availability of the evaluation 
results on time. It is fundamental to have sufficient internal and/or external staff able to 
deal with the process and communicate effectively with the beneficiaries, together with a 
detailed planning of the implementation of the evaluation to allow supervision and 
troubleshooting. 
In this regard, it is recommended that the responsible authorities prepare thorough 
evaluation plans, which should identify at least the following: 
• the resources needed to carry out the evaluation;  
• the work plan with a timeline and clear deadlines to allow follow-up and review of 
the progress; 
• the procedures to check and validate the results of the evaluation. 
If the evaluation is carried out by an external consultant, the work plan should allow 
sufficient time for contracting (including for preparation of the terms of reference, launch 
of the call for tenders, selection of the contractor and signature of the contract). 
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In addition, the time margin necessary for carrying out the quality assessment of the 
deliverables needs to be taken into account in the end of the contract. 
Finally, in their evaluation plan, responsible authorities should also foresee the strategy 
and approach in disseminating the results of the evaluation of the interventions funded 
within the food chain area. 
 
6.1.3 Selecting the evaluation experts: Terms of Reference (ToR) 
 
It is vital that the evaluation is carried out by experts who are functionally independent 
from the responsible authorities, the audit authorities and the delegated authorities. This 
implies that the Commission or the Member States have the choice to entrust the 
evaluation to external experts (contractors), or to an internal but functionally 
independent body. Under the second option, these experts may be affiliated to an 
autonomous public institution responsible for the monitoring, evaluation and audit of the 
administration. The hierarchical independence of the evaluators should be ensured 
through an appropriate assessment of the situation32. 
Depending on the option selected, procurement may be necessary. or not.It is 
recommended to set up a detailed plan and to write precise Terms of Reference 
(hereafter referred to as the ToR). 
 
Preparing Terms of Reference (ToR)33 
 
The ToR presents an overview of the evaluation manager’s requirements and 
expectations related to the evaluation study, providing a brief and concise description of 
the main scope and purpose of the evaluation, the roles and responsibilities of the actors 
involved, the methodology, the selection criteria, the timeline, and the amount of 
resources available for the evaluation (if applicable). 
The ToR discusses the logical connection between several elements: the rationale for the 
evaluation, the objectives of the fund, the purpose of the evaluation, and the evaluation 
questions. The ToR should be structured to include the following key elements: 
1. Background introduction and description of the intervention providing context 
information and the objectives of the fund. 
2. Specific purpose and scope of the evaluation, explaining what will be evaluated 
and why, complemented by the main evaluation questions.  
3. Intervention logic with the expected broad methodological approach, wide enough 
to ensure room for the evaluators to assess the quality of the proposed methodologies 
and if appropriate suggest additional/alternative ones.  
4. Evaluation questions encouraging critical analysis. The evaluation questions 
selected by the Commission should be worded in a way that forces the evaluator to go 
beyond providing a yes/no answer based on simple description, and to look at what the 
links were between the changes observed and the EU interventions. 
                                           
32 For more information one can check the Better Regulation Guidelines  
https://ec.europa.eu/info/sites/info/files/better-regulation-guidelines.pdf 
33 A set of supporting material to write a Terms of Reference including suggestions is available on the 
Competence Centre on Microeconomic Evaluation website: https://crie.jrc.ec.europa.eu/?q=content/tor 
Advice on the on the qualifications of the evaluation team is provided in the 5. Selection and Award criteria 
of the guideline: https://crie.jrc.ec.europa.eu/sites/default/files/GuideTermsReference.pdf . 
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5. Availability of relevant data (e.g. outcome measures, covariates) on the target 
population directly provided by the commissioning authority or publicly available. 
6. Availability of data on the control group if Counterfactual Impact Evaluation 
methods are being used. 
7. Description of the required professional competences and qualifications of the 
evaluators (according to the scope and methodology of the evaluation) as well as of the 
selection and award criteria. 
The ToR should indicate the minimum requirements on size and experience profile of the 
evaluation team, the qualifications of the principal investigator, the necessary human and 
technical resources, and the distribution of responsibilities among team members to 
perform the proposed work and demonstrated specific experience usually from relevant 
evaluations performed in the past. 
For an impact evaluation and cost-effectiveness analysis in the Food chain area such as a 
case study described in chapter 7, one would need at least one expert in econometrics 
and counterfactual impact evaluation methods and one (Public Health) expert in the 
relevant field of the evaluation (animal health, plant health, food safety). 
8. Expected tasks and deliverables (inception, intermediate and final reports, 
presentations, other documents expected from the evaluators), the time schedule of the 
study and the available budget. 
In order to provide an additional safety net, ensuring a high editorial quality of the 
contractors' final report, it is recommended to consider including the following clause in 
the ToR: "In view of its publication, the final report by the contractors must be of high 
editorial quality. In cases where the contractor does not manage to produce a final report 
of high editorial quality within the timeframe defined by the contract, the contracting 
authority can decide to have the final report professionally edited at the expense of the 
contractor (e.g. deduction of these costs from the final payment)." 
Finally, the ToR should contain detailed information on the methodology that it is 
advisable to adopt for the evaluation. Different methodologies can be used depending on 
the data at hand. Responsible Authorities can choose to be very prescriptive and to 
describe in the ToR which data collection tools and analytical methods shall be used, or 
request the evaluation experts to propose their approach and methodology, and use 
these as one of the criteria for the selection of the experts. However, the ToR should 
specify that triangulation of methods is required. 
The contractors should be asked to explain in their bid the advantages, the limitations 
and the risks involved in using the proposed tools and techniques. 
To make this step smooth it is important that the Responsible Authorities are in touch 
with the beneficiaries of the funds in terms of data availability and collection. During the 
inception phase of the evaluation, the evaluators may be asked to refine the 
methodology proposed in the tender bid and to provide further details on the data 
collection tools, sources, analysis methods, data limitations and back-up solutions. 
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6.2 Data requirements 
 
6.2.1 Types of data needed 
 
Performing cost-effectiveness analysis requires collecting information on: 
• The entire population under evaluation that is not only the regions/holdings, 
individuals receiving the intervention but also the existing control groups. 
• The follow-up time period of the evaluation; before and after the introduction of 
the intervention or/and until the effects are expected to occur. 
• The chosen effectiveness indicators; output, result or impact indicators for each 
observation unit and time period. 
• The costs in relation with the view point followed in the evaluation, EU funding, 
but also the part of the interventions funded by the MS or privately. 
• A set of “control variables” which are all potential confounding factors or 
contextual indicators of the effect under evaluation, such as qualification levels of 
official controllers, their age and gender, etc. when evaluating the BTSF 
programme. 
• The level of observation unit could be the region, the holdings, and the individuals 
depending on the study question and of the data availability. 
 
6.2.2 Data provisions 
 
To ensure that the necessary data are available in time the evaluation needs to be 
performed, this section lists guiding questions specific to data planning and collection. 
 
• Plan: How will data be collected or accessed?  
Whenever possible, data collection and data organization should be (a) no (or only a 
limited) burden to beneficiaries and (b) centralised (for simplification and uniformity). 
One should assess when sufficient data will be available and ready to perform the 
evaluation. One would also need a plan to enhance collection and management of 
data. 
• Data sources: Are there data already collected that could be used for evaluation? 
A. Outcome, output and impact indicators, and contextual indicators:  
 
Valuable data are already collected by the EC that could be used for evaluation within the 
Food chain area, such as: 
-      Web based notification system for Harmful organisms, EUROPHYT-Outbreaks                                            
https://ec.europa.eu/food/plant/plant_health_biosecurity/europhyt/network_en 
- EUROSTAT: http://epp.eurostat.ec.europa.eu/newxtweb/ 
- FADN, Farm Accountancy Data Network: https://ec.europa.eu/agriculture/fadn_en 
- MADB, Market Access database: http://madb.europa.eu/madb/indexPubli.htm 
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- The new platform: “Electronic Official Controls of Food and Plant Products”  
- TRACES, TRAde Control and Expert System: 
https://ec.europa.eu/food/animals/traces_en 
- RASFF, Food and Feed Safety Alerts: https://webgate.ec.europa.eu/rasff-
window/portal/?event=SearchForm&cleanSearch=1 
 
B. Cost and financial data 
 
Cost information is collected through online templates that MS are requested to fill in 
to receive financial support each year: 
• Record information on output and (result) indicators (number of tests, visual 
inspection, vaccination, number of farms tested, type of farms, number of 
infection detected, number of outbreaks, etc.) 
• Record geographical information: region, local areas in the MS in which the 
measures were implemented. This information is important and need to be link 
with the corresponding cost and type of activities funded per geographical unit 
at the most disaggregated level. 
• The co-funding rate, source of funding: public or private. 
 
Data collection: what information and how data should be collected? 
 
The data for the analysis should be prepared in a format that can be read by the software  
used for the evaluation. This can be either Excel or delimited text file (see an example of 
a set of data in Annex 2). If the data required for analysis, - financial and technical - are 
not part of a harmonized data system but are stored in separate datasets, it is crucial 
that a common identifier is included in each dataset to allow linkage. 
For an evaluation at the EU level of the interventions funded within the Animal health 
spending area, one common identifier could be the NUTS or regional unit to link the 
financial data with other sources of data such as EUROSTAT or data collected via the 
Animal Disease Notification System (ADNS). 
When individual data are required as for the evaluation of the training activities within 
the Official controls spending area, the datasets would require an anonymised common 
identifier to guarantee the non-identification of training participants. 
To facilitate high quality and reliable impact evaluation it is advised to preparedata as 
granular as possible. 
It is also crucial that the legal text clarifies what data shall be collected and what data 
can be shared within DGs and with external contractors.  
It would be relevant to keep information on non-successful applicants also to be used for 
later ex-post evaluations as counterfactual group.   
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Box 6: Implementation requirements 
The methodology described in this report to measure the impact and the cost- 
effectiveness of the interventions funded under the food chain area is an in-depth-data-
driven technique. This technique is grounded on micro data and provides robust ex-post 
evidence on the impact and the efficiency of interventions.  
This method then requires: 
— careful planning of the evaluation of the interventions, and 
— in particular on data requirements: 
— use of data already collected also for other purposes (cost information, effectiveness 
indicators, contextual indicators) 
— use of data at the least aggregated level 
— plan harmonised data collection  
— ensure the legal arrangements for data collection and sharing 
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7 Case studies 
 
Given the different nature of the indicators to evaluate the effectiveness of EU co-funding 
in the food chain area and the different perspectives in which the interventions, a CEA 
must provide an answer for a particular policy question. In this section, examples of cost-
effectiveness analyses in the context of interventions co-funded in the CFF are provided 
which could be performed in collaboration with JRC. 
The presented cases are not exhaustive with respect to the CEA that can be conducted 
but provide examples of relevant policy questions and how the methodologies considered 
in this report can be used to address them.  
They are presented by discussing the: policy question, the motivation, the intervention 
under evaluations, the outcome variable, the CER implicit in the NBR, the scope of the 
analysis, the suggested time frame for the analysis, the outcome variable, the control 
variables, the cost perspective, and possible selection problems. 
Case study 2 is described in more details. In particular, an example of estimation of the 
cost-effectiveness indicator based on simulated data is reported in Box 7. 
7.1 Case study 1  
 
Policy question: what is the cost-effectiveness of the introduction of e-learning 
compared to workshops in the programme BTSF? 
Motivation: e-learning is a training tool that reaches more people at lower cost; 
however the learning approach is different from workshops since those allow a bigger 
interaction between trainer and trainees and lecturing is complemented by field work and 
case studies. However assuming that acquired knowledge can in both cases be assessed 
and comparable, the aim is to evaluate how cost effective is the introduction of e-
learning. 
Interventions:  Spending in workshop versus spending in workshop + e-learning. 
CER method: The Incremental CER, as two types of trainings are compared.  
Scope: The observational units are the individual participants in the training sessions.  
Follow-up time: at least one year before and one year after the introduction of e-
learning modules 
Outcome variable: Test score (result indicator). The Cost-effectiveness will be 
measured as the cost per additional point in the test score. 
Control variables: individual qualifications and experience, MS identifier, participation in 
previous training sessions. 
Cost perspective: It matters to consider the analysis not only at the EU level, but also 
MS and participants’ private costs. 
Selection issue: CIE might have to be used as participation in the training sessions is 
not compulsory. 
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7.2 Case study 2: Economic evaluation of the veterinary 
programmes for O&CB, ASF, rabies, CBSE, ZS, CSF 
 
7.2.1 Description and objective of the programme 
EU co-funding in veterinary programmes builds up on the results achieved in the recent 
past on eradicating and controlling the prevalence of different diseases that have an 
impact also on human health, trade and farmers. Since veterinary programmes may 
have a multiannual nature, their implementation needs to be continuously evaluated. 
New measures have been implemented in MS and EU funded such as vaccination in 
particular as prevention measures. These new measures increased the EU funding spent 
in veterinary programmes.  
7.2.2 Policy question 
Tracing the different intensities of veterinary programmes in EU regions over time and 
measure what is the effectiveness of an increase/reduction in the EU spending on 
eradication and control interventions within veterinary programmes for the following 
diseases: O&CB, ASF, rabies, CBSE, ZS and CSF. 
The cost perspective will be the one of the EC. What is the effectiveness of EU funding on 
reaching the target set by the Commission for each disease? 
7.2.3 Identification of a control group and scope of the analysis 
Veterinary programmes are awarded to regions where a disease is present. It is not 
reasonable to assume that there are regions infected (with the same risk) that do not 
apply for co-funding. In this case, the entire target population receives funding and there 
is no selection issue (as explained in sections 4.1.2 and 5.1.2).  
Given the policy question, the cost-effectiveness indicator used is the marginal cost-
effectiveness ratio (MCER) to measure the impact of an increase of EU funding using 
variation of EU funding over time across regions and diseases. 
The observational units are the regions34 targeted by veterinary programmes. 
As the estimation of the MCER relies on variation over time and given that the impact of 
veterinary programmes on the presence of the analysed diseases (O&CB, ASF, rabies, 
CBSE, ZS and CSF) can occur also a number of years after the implementation of the 
measures, the more data on previous funding periods and presence of the diseases are 
available (backward in years) the better. 
7.2.4 Data  
Measuring the costs  
EU funding: it is crucial to have access to precise and detailed information on the 
amount of EU funding that each region receives for each disease within the veterinary 
programmes. Moreover, it is essential that a measure of national co-funding (total 
amounts of the payments by each MS or, if missing, the co-funding rate) is provided at 
the same regional level at which the analysis is conducted. This information should be 
made available every year by MS that receive EU funding in the annual technical and 
financial report (Art. 14 of Regulation (EU) No 652/2014). 
                                           
34 The regions targeted by the EC i.e. regions in which the disease is present or regions in which there is a risk 
of disease  
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National Funding: in addition to the co-payments to EU funding, it is necessary to 
retrieve information on any other financial contribution pertaining to veterinary 
programmes that each MS supplies at the NUTS2 regional level. 
Measuring the effectiveness  
The effectiveness of the eradication and control programmes can be measured in a given 
region, a given year and for a given disease as the distance from the target set by the 
Commission. Hence, the effectiveness increases when the distance decreases. This can 
be expressed either (i) as a continuous measure of distance from the target that is 
normalised across diseases, or (ii) as a dummy variable for whether the target was 
reached (i.e. equal to 1 if the target was achieved, and 0 otherwise). The choice of the 
type of variable used (continuous or dichotomous) depends on the quality of data 
available. Yet, in both cases, to be able to compute the distance from the target it is 
necessary to have information on the number of cases/outbreaks35 and the actual targets 
for each disease (Result Indicator). 
Contextual indicators 
A set of contextual indicators including: GDP, farms indicators such as the number of 
farms, the number of livestock and the standard output are available on EUROSTAT. 
Other relevant contextual indicators to include are the year of first outbreak; the number 
of secondary outbreaks and other risk indicators to assess the epidemiological situation 
in the region, the existence (or/and amount) of national funded actions to eradicate, 
control and survey these diseases complementary to the EU-funding. 
7.2.5 Cost-effectiveness indicators and interpretation 
The cost-effectiveness indicator used to estimate the impact of EU funding in veterinary 
programmes on the distance to the target at the regional level is the cost per percentage 
point decrease in the distance from the target. Box 7 provides an illustration of the 
potential estimation results. 
In this case, the cost-effectiveness indicator does not measure the impact of the 
veterinary programme compared to the counterfactual situation of no veterinary 
programme but measures the marginal (increase/decrease in funding over time) cost 
effectiveness of the veterinary programme compared to the same programme before the 
quantitative/qualitative change in the funding/programme. As the policy question is not 
about knowing and measuring whether the EU should fund veterinary programme or not 
but rather how much money should be given to MS, the most relevant cost-effectiveness 
indicator is the marginal cost effectiveness indicator. 
We estimate the MCER for all the listed diseases combined; hence, the estimated MCER 
can be interpreted as the average marginal effect of funding for these specific diseases.  
The identification of the cost-effectiveness of the veterinary programmes on the distance 
to the target relies on the quality of the data/information on contextual factors collected 
and introduced in the estimation. The panel nature of the evaluation (region, disease and 
time variations) allows introducing time, disease and country fixed effects to control for 
any unobservable heterogeneity. 
  
                                           
35 The EC defines the target as a number of cases or outbreaks depending on the disease as defined in WD 
SANTE/2017/10186.  
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Box 7: Estimation results of case study 2 using simulated data  
 
PLEASE NOTE THAT THE RESULTS HEREIN PRESENTED DO NOT REFLECT 
REALITY AND ARE USED FOR ILLUSTRATION PURPOSES ONLY. 
 
The analysis considers the econometric methodology as proposed in section 5.3, which is 
reported below for the reader’s convenience. 
To compute the MCER of case study 2, the following equations are estimated: 
)!*3M = 45 + 4783M + 3M9 + :3M, 
(( *!!3M = ;5 + ;783M + 3M9 + :3M, 
 
The net benefit regression (NBR) to be estimated for region i, disease j and year t is: 
'<N= = L5 + L783M + 39 + :3M, 
 
In this specific setting, each term of the regression equation is defined as follows.  
where )!*3M is defined as the total funding received by each region in a given year for a 
given disease and the (( *!!3M is measured as the distance from the target for 
each disease. In the general case we consider a dummy variable that takes value 1 if the 
target was reached in a given region, a given year and for a given disease, and 0 
otherwise.  
83 is a variable that takes value 1 if the NUTS region has received funding for the 
veterinary programme in a given year for a given disease and value 0 otherwise. 
3 is a set that contains the following variables: 
— Standard output (agricultural sector) for each NUTS region and each year, 
— GDP for each NUTS region and each year, 
— Number of farms for each NUTS region and each year, 
— Number of outbreaks in the previous year for each NUTS region, each disease and 
each year, 
— National funding that is not related to EU funding for each country and each year, 
— Whether the region has received funding for the National veterinary programme in 
the previous year for each NUTS region, each disease and each year, 
— A country fixed effect, 
— A disease fixed effect, 
— A year fixed effect. 
'<N= is a measure that encompasses the Net Monetary Benefit of the control programme 
and corresponds to the general formula described in section 1.3: 
J8K ∗ ∆ −∆ 
This is computed as the difference between the willingness to pay (WTP) parameter 
multiplied by the effectiveness of the veterinary programmes measured as the distance 
from the target set by the Commission (as defined in WD SANTE/2017/10186) in a given 
region and a given year for each disease and the cost of the intervention in terms of EU 
funding spent on the veterinary programme. 
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Based on the simulated data (from which an extract is presented in Annex 2), the 
marginal effectiveness ratio (MCER) is:  
MCER =
∆
∆
=
41
;1
=
40166	
10
= 4	016.60 
The additional cost of a ten percentage point increase in effectiveness measured as the 
reduction in the distance from the target is 40 166 EUR on average per year, region and 
disease. 
Figure 2 displays the cost-effectiveness plane to represent the uncertainty of this MCER 
using bootstrapping with 1,000 iterations. Figure 2 shows the points are located in the 
quadrant I (cf. Chapter 1), indicating that the increase in EU Funding produces an 
increase in effectiveness (i.e. a reduction in the distance to the target).  
In this area there is a trade-off between effect and cost: a reduction of the number of 
cases can be obtained but at higher cost. The question which then arises is whether or 
not the trade-off is acceptable, i.e. whether the effectiveness gain is worth the additional 
cost. This decision is based on the MCER and what the decision-makers are willing to pay 
for the additional effectiveness, i.e. the Willingness to Pay (WTP). 
Figure 3 reports the estimates of the Net Benefit Regression showing the increase in 
effectiveness for different values of WTP.  
The above ratio measures an overall MCER for all the listed diseases combined. 
Nonetheless, one can also run similar regressions separately for each disease (i.e. on a 
sub-sample of the one considered above) to calculate the MCER for each disease. Note 
that this is only feasible provided that there is a reasonable number of an observation.  
For example, in the case of a single disease (e.g. ASF), the marginal effectiveness ratio is 
MCER =
∆
∆
= 41
;1
= 	31292
10
= 3129.20	  
In this case, the additional cost of a ten-percentage point reduction in the distance from 
the target set by the Commission for ASF is 31292 EUR per year per region. 
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Figure 3 – The cost-effectiveness plane for the veterinary programme in Animal Health 
 
Source: Average marginal cost-effectiveness estimates for O&CB, ASF, rabies, CBSE, ZS, CSF. Authors’ own 
estimations based on simulated data 
Figure 4 – Net Benefit for the National veterinary programme in Animal Health 
 
Source: Authors’ own estimations based on simulated data 
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7.3 Case study 3  
Study question: what is the cost-effectiveness of the spending in plant health 
emergency measures? 
Motivation: Plant pest outbreaks are a constant threat in the EU territory. There are 
many possible sources including exposure to infected neighbouring third countries. Cost-
effectiveness of emergency measures for pests occurring in the EU territory is relevant 
when assessing its efficacy but also when evaluating relevant indirect impacts for farmers 
in Europe. 
Interventions: Tracing the different intensities of emergency measures in EU regions 
over time. 
CER method: Marginal CER interpretation of the ICER as the intervention is the same 
overtime. 
Scope: The observational units are the regions under emergency measures. 
Follow-up time: will depend on the disease characteristics, but control for past 
outbreaks, two CFF funding periods should be covered. 
Outcome variable:  
a. Indicator variable of whether the eradication programme was successful (Result 
Indicator).  
b. Productivity indicator (Impact indicator) 
Control variables:  
a. Type of disease; year of first outbreak; number of secondary outbreaks; MS 
identifier; existence (or/and amount) of national funded actions to eradicate 
diseases complementary to the EU-funding;  
b. Average size farm, capital intensity, MS identifier etc.  
Cost perspective: It matters to consider the analysis not only at the EU level, but also 
MS and farmer 
Selection issue: Emergency measures  co-fund measures once an outbreak as occurred 
and timely action has been taken. It is not reasonable to assume that regions infected do 
not apply for co-funding. 
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Annexes 
Annex 1. Literature Review on the cost of outbreaks 
 
Introduction 
 
In many countries, agricultural and livestock sectors play a fundamental role in the 
national economy as food production is a source of valuable income, employment and 
international trade. Outbreaks of diseases affecting animals and plants are therefore a 
source of considerable concern due to the magnitude and variety of economic impacts 
that they could entail.  
Cases of Bovine spongiform encephalopathy have been detected, for example, in the 
United Kingdom in 1996/1997 when a total of 6,271 animals have been slaughtered as 
well as in Germany with a total of 413 BSE cases confirmed from November 2000 
onwards. The Netherlands has been hit by Classical Swine Fever (CSF) in 1997/1998 for 
a period of eighteen months and a total of 11 million animals slaughtered. Foot and 
Mouth Disease (FMD) has infected over 0.7 million animals in United Kingdom in 2001 
and 6.24 million have been slaughtered (FAO, 2002). In August 2006, North-Western 
Europe’s first Bluetongue virus serotype 8 (BTV8) outbreak was detected in the 
Netherlands. Finally, according to FAO (2008), the year 2006 was identified as the ‘peak’ 
of the highly pathogenic avian influenza (HPAI) H5N1 with 60 countries reporting 
outbreaks. The total number of confirmed human cases was 115 of which 79 were fatal 
(WHO, 2015). For what concerns plant pests, since October 2013 Xylella Fastidiosa has 
caused large economic damages to the olive oil industry in Apulia (Italy). 
Large scale outbreaks of animal diseases and plant pests can be extremely costly. As 
stated by Bennett (2003), the consequences of diseases are not limited to the direct 
economic losses but extend also to indirect impacts. The former category should include 
the reduction in the level of marketable outputs, a reduction in output quality, a waste of 
inputs and resource costs associated with disease prevention and control. The latter 
category accounts for human health costs associated with diseases or disease control, 
negative animal welfare impacts and international trade restrictions due to disease and 
its control. Furthermore, diseases outbreaks may have economic consequences even in 
other sectors of the economic system. For example, the outbreak of Foot and Mouth 
Disease in the UK in 2001 affected not only residents of rural areas but also other UK 
residents who could not visit rural areas because of the implementation of a temporary 
policy that limited access to them. Moreover, the touristic sector was affected as well 
because foreign tourists who considered the UK as a potential destination were prevented 
from visiting rural areas. 
This chapter aims at providing a review of the literature about the economic costs of 
diseases outbreaks. The literature on the costs of outbreaks in the food chain area is 
rather scant. Pritchett et al. (2005) reviewed the literature on the economic impacts of 
animal diseases by distinguishing the studies according to the level of analysis, ranging 
from the individual producer level to the national level. Morgan and Prakash (2006) 
reviewed the factors and trends underpinning the growth in meat trade over the past 
decade and assess the impact of animal diseases on international markets. Rushton and 
Lyons (2015) described the most relevant contributions in the extant literature on 
production related losses due to Bluetongue. By focusing on methodological approaches, 
Gethmann et al. (2015) presented a brief overview of the methods used to 
retrospectively analyse the economic impact of two particular relevant diseases in 
Germany in the last few years: Bluetongue disease and Bovine Spongiform 
Encephalopathy. Finally, Ward (2016) reviews some past pest outbreaks by focusing on 
the variation in the costs depending on the timing of the intervention. According to the 
authors, visible symptoms lag behind the arrival of a pest in a new area and noticeable 
damage lags behind early symptoms. Hence, diagnosis and awareness tend to appear 
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sometime after the damage. Furthermore, the less evident the damage, the lower the 
willingness of the stakeholder to spend on measures. The progression may take several 
years during the course of which the actual benefit to cost ratio of any action is likely to 
decline. As a pest spreads the cost of measures tends to increase in proportion to the 
area infected, and the likelihood of successful eradication or containment falls rapidly. 
Political willingness to commit resources therefore increases just as the cost effectiveness 
of doing so becomes more doubtful.  
Our review differs from previous reviews in a number of ways: first, it focuses on both 
direct and indirect costs; second, it is not limited to a specific type of plant or animal 
disease; third, it covers a long period of time (from 1997 to 2017); fourth, it does not 
consider outbreaks in a single country but extends to the whole Europe, North America 
and Australia. Reviewed studies have been categorised according to: the kind of disease, 
the typology of economic costs involved in the analysis and the methodological approach 
used to estimate economic impacts, i.e. deterministic or simulation approach.  
The rest of the chapter is organized as follows. The next section describes the 
methodology used for the identification of relevant studies. Then, the results of the 
literature review are presented and discussed on the basis of the typology of the costs, 
the factors determining the magnitude of the impacts and the methodological approach. 
Finally, the last section concludes.  
 
Methodology 
 
a. Search Strategy 
The literature search aimed at identifying studies dealing with the evaluation of economic 
costs of plant and animal disease outbreaks. The following databases have been searched 
in July 2017 from their inception dates to present: Scopus, Google Scholar, and Pubsy. 
Searches are designed to identify studies on costs of plant and animal diseases outbreaks 
in Europe, North America and Australia from 1997 onwards. The search has been 
conducted by combining the concepts of ‘animal disease’ or ‘plant pest’ and ‘outbreak’ or 
‘crisis’ with the concepts of ‘cost analysis’, ‘cost evaluation’, ‘economic impact’. Full 
details of the search strategy for Scopus database is presented in the Additional Material 
and full search strategies for all databases are available from the authors upon request. 
Bibliographies of included studies were also searched for relevant studies. 
b. Inclusion Criteria 
To be eligible for inclusion studies had to evaluate economic costs of either food or 
veterinary or phytosanitary crisis. Only studies where the impact of an outbreak was 
measured in terms of economic costs were selected for full review. 
Studies that reported qualitative data, literature reviews, studies that lacked quantitative 
data, studies in countries different from Europe, North America and Australia as well as 
studies written in a language other than English were excluded. 
Moreover, studies that evaluated the cost-effectiveness of alternative control strategies 
for the eradication of the disease were excluded, as the main focus of the review was to 
analyse the direct and indirect costs of outbreaks.  
The focus is on specific diseases for which outbreaks have been observed in recent 
decades across the countries of interest (e.g. Avian Influenza, Bovine Spongiform 
encephalopathy, Foot-and Mouth Disease, Classical Swine Fever, Bluetongue and Foot 
and Mouth Disease).  
Finally, only studies referred to outbreaks that occurred in the period 1997-2017 were 
considered. 
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c. Data collection and analysis 
To select studies for the review, titles and abstracts were screened using the above 
inclusion criteria and this process was managed using the Mendeley software. When the 
decision to include or exclude a study was not straightforward, a second reviewer was 
consulted to resolve uncertainty. The detailed process of articles selection is presented in 
a PRISMA chart in the Additional Material (Liberati et al., 2009).  
Once the included studies were identified, data were extracted using a data extraction 
form developed for this purpose. For each study the following information have been 
selected: type of disease, analysed country, and methodological approach of the paper, 
description of either the outbreak or the simulated scenarios, type of costs considered in 
the analysis and main results. Due to the substantial differences in interventions, setting, 
disease area, and sample, a meta-analysis was not conducted. Instead, a narrative 
summary of the included studies is presented below.  
 
Results 
 
a. Methodological approaches 
From a methodological point of view, papers estimating economic costs of diseases 
outbreaks may be divided into those dealing with real outbreaks and simulation studies. 
The former category encompasses those studies looking at the economic costs of 
outbreaks that took place between 1997 and 2007 either in North America or Europe or 
Australia. On the contrary, the latter group of papers simulate the occurrence of an 
outbreak and estimate its potential consequences. The results show that 21 studies focus 
on real outbreaks while the remaining 14 are simulation analysis.  
Specific outbreaks that have received more attention are the Foot-and-Mouth Disease in 
the United Kingdom in 2001 (3 studies) and the 1999 Xylella Fastidiosa epidemic in 
California (2 studies). The diseases with the highest number of reviewed outbreaks are 
the Bovine Spongiforme Encephalophaty and the Salmonella while the country where the 
highest number of reviewed outbreaks occurred is the United Kingdom, with the 2001 
Foot-and-Mouth Disease, the 1996/1997 and 2000 Bovine Spongiforme Encephalophaty, 
the 1998 Bovine Tuberculosis, the 2010-2015 Avian Influenza and the 1999 Salmonella 
outbreaks.  
For what concerns simulation studies, five out of fourteen deal with human influenza 
pandemic potentially caused by avian influenza while other two assess its economic costs 
without assuming human contagion. Simulation studies then concentrate on potential 
African and Classical Swine Fever (CSF) outbreaks as well as on hypothetical Foot-and-
Mouth Disease episodes. Papers adopting this methodological framework are well 
distributed over geographical areas of interest and one of them provides worldwide 
estimates.  
 
b. Typology of costs 
Outbreaks of animal diseases are likely to have negative consequences on the economic 
system. Generally speaking, total economic costs may be calculated as the sum of direct 
and indirect costs. The former category represents the loss of profitability of the 
production system while the latter encompasses both the costs associated to disease 
controls as well as the impact on sectors other than the agricultural one (Rushton, 2009 
and Dijkhuizen and Morris, 1996). 
Direct costs may be evaluated at the farm level. According to Bennet (2003), direct costs 
consist of two components: losses and expenditures. On the one hand, the value of the 
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loss in expected output accounts for both the visible effect of the disease on livestock 
outputs as well as for the invisible production losses. The former includes, among the 
others, milk yields reduction, wool production decrease, animals’ infertility and mortality; 
the latter refers, for example, to the delay in the sale of animals. On the other hand, the 
presence of an outbreak may increase expenditures on non-veterinary sources, such as 
feed and farm labour, and may require a larger amount of resources to be spent on 
disease treatment (to mitigate the consequences of disease after infection) as well as on 
prevention measures (to prevent further occurrence of the infection). Hence, direct costs 
represent the variation in gross margins following the outbreak. The difference between 
change in output and change in variable costs (in both cases with respect to “business as 
usual”) indicates the response in terms of profitability to a shock to the production 
system (Gethmann et al., 2015). 
The assessment of the economic importance of diseases usually follows the works by 
Bennet et al. (1999) and Bennet (2003). The authors focus only on direct costs 
associated with a disease, defined as the value of the loss in expected output and/or of 
resource wastage due to the disease, together with the treatment costs incurred in trying 
to mitigate the effects of disease on production and the costs associated with specific 
disease prevention. A standardized methodology is applied to the estimation of the direct 
costs associated with each disease and a spreadsheet model is used to enable a 
transparent financial estimation of the direct costs whilst still providing a realistic 
representation of the impact of each disease on production.  
According to Bennet et al. (1999) and Bennet (2003), direct costs (C) are defined as: 
	 = 	V + 8 + K,	
where L is the value of the loss in expected output and/or of resource wastage due to the 
disease, T are the treatment costs incurred in trying to mitigate the effects of disease on 
production and P are the costs associated with specific disease prevention. 
The methodology to estimate direct disease cost involves: 
1. Identification of the livestock populations at risk and the production systems 
affected and estimation of the incidence or prevalence of each disease in these 
populations. 
2. Identification of the range and incidence of physical effects of each disease on the 
production systems affected (i.e. compared to what might be expected without 
the disease being present). 
3. Valuation of the physical effects of each disease on production.  
4. Estimation of the value of the direct disease losses to livestock production due to 
the disease.  
5. Identification of the treatment measures undertaken for each disease and 
estimation of treatment costs incurred due to the disease.  
6. Identification of specific prophylactic measures for each disease and estimation of 
the costs incurred in undertaking those measures. 
Using this approach, a simple spreadsheet model was constructed for each disease which 
estimated the components of the direct cost measure defined above where: 
L = p	iZi[e	v< for each disease effect 
T = p	i=v= for each type of disease treatment 
P = p	i^v^ for each type of disease prevention 
Here, p is the size of the livestock population at risk, iZ the annual incidence of disease as 
a proportion of the population at risk, i[ the incidence of disease effects as a proportion of 
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the affected population, e the magnitude of physical disease effects, v< the unit value of 
lost output or resource wastage, i= the proportion of the population at risk treated, v= the 
cost of treatment per animal, i^ the proportion of the population at risk where prevention 
measure is taken, and v^ the cost of prevention measure per animal. 
Disease outbreaks may also have indirect costs that accrue at the regional, country or EU 
level. On the one hand, indirect costs are related to the set of measures taken to 
prevent, diagnose and control the disease through compulsory vaccination programmes, 
insecticide treatment, epidemiological investigations, culling, monitoring/surveillance and 
removal of specified risk materials. On the other hand, indirect costs may refer to the 
economic impact of the outbreak on national markets due to change in domestic 
consumer perception as well as to export losses due to international trade restrictions. In 
particular, the international market of a specific good may experience change in price, 
shift of market shares between exporters and a variation in consumption from that good 
to a substitute. Moreover, other sectors of the economic system may be affected by 
disease outbreaks. The 2001 Foot-and-Mouth disease outbreak in the United Kingdom 
has shown how tourism and recreational activities are the most prone to suffer economic 
losses mainly because of restrictions access to the countryside (Blake et al., 2014). 
Finally, other indirect costs include human health costs associated with diseases or 
disease control, negative animal welfare impacts associated with the disease and increase 
need for research.  
Direct economic costs have been evaluated by a high number of papers: nine out of 
twenty-one among the studies analysing the economic consequences of a real outbreak 
and six out of nine among the studies evaluating the potential impact of simulated animal 
or plants diseases. Two studies look only at eradication programmes costs. 
Indirect economic costs may be differentiated into a variety of sub-categories. First of all, 
animals or plants diseases outbreaks may have an impact on the overall GDP, which 
accounts for both direct economic costs and for the costs to the other sectors of the 
economy. Three papers out of the twenty-one analysing the economic consequences of a 
real outbreak estimate the overall GDP impact while all the papers simulating an 
influenza pandemic report the figure. Similarly, two studies among those dealing with 
simulated outbreaks of animals or plants diseases evaluate the variation in total welfare 
calculated as total discounted economic gains and losses and cost to producer, consumer 
and government over a certain period of time following the outbreak. 
Secondly, outbreaks may affect international markets. On the one hand, animals or 
plants diseases outbreak are likely to decrease product’s demand because consumer 
confidence decreases; on the other hand, export bans are usually applied to those 
countries experiencing the outbreak. Reduction in demand for exports and fall in export 
prices have been analysed by nine papers in total.  
Finally, indirect costs may be disease specific. For example, all the three papers dealing 
with the 2001 FMD outbreak in the UK provide estimates on reduction of tourism 
expenditures. The reduction in this kind of recreational activity may happen because of 
access restrictions to affected areas and because people themselves prefer not to visit 
regions where the disease is spreading. Other types of diseases, e.g. salmonella and 
rabies, may entail health costs, which have been estimated by three papers among those 
selected for the review.  
 
c. Cost estimates 
In the table that follows (Table A), a summary of the selected papers is presented, which 
are classified by typology of costs analysed. The information in the table includes the 
estimated costs and whether the study is based on a real or simulated scenario.  
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Table A: Classification of studies by typology of costs and results 
 
Outbreak / 
Scenario 
Real / 
Simulated 
Outbreak 
Direct 
Impacts 
GDP Welfare 
International 
Mkts 
Tourism Eradication Health 
Thompson et al. 
(2002) 
FMD, UK in 2001 Real £3.1 billion    £2.7-£3.2 
billion 
  
Blake et al. (2014) FMD, UK in 2001 Real  
£2.1-
£2.6 
billion 
  £6.7-£8.8 
billion 
  
Royal Society of 
Edinburgh (2002) 
FMD, Scotland in 
2001 
Real  £2.4 
billion 
  
£200-£250 
million 
(Scotland) 
  
Atkinson (1999) BSE, UK in 
1996/1997 
Real  £1 billion  £1.5 billion    
Mathews et al. 
(2003) 
BSE, UK in 2000 Real    
Exports 
decline: 30%-
40% 
   
Park et al. (2006) BSE, US in 2003 Real    
Demand loss: 
$4.6 million    
Velthius et al. (2015) BTV, Netherlands in 
2006/2007 
Real 107€-134€ 
million 
      
Gethmann et al. 
(2015) 
BTV, Germany in 
2006-2011 Real 
200€ 
million       
Bennett and Cooke 
(2006) 
BT, UK in 1998-2000 Real £18,000 
per farm 
      
Caminiti et al. 
(2016) 
BT, Italy in 2007-
2011 Real      19€ million  
Mazzocchi et al. 
(2007) 
AI, various countries 
in 2005 
Real    Imports 
decline: 10% 
   
Siettou (2016) AI, UK in 2010-2015 Real    No variation    
Meuwissen et al. 
(1999) 
CSF, Netherlands in 
1997/1998 Real 2.4 billion       
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Damaso and Rushton 
(2017) 
Salmonella, Wales in 
1999/2001 Real 
£19,000 
per farm       
Ailes et al. (2013) 
Salmonella, City of 
Alamosa, Colorado in 
2008 
Real       
$2.6 
million 
Suijkerbuijk et al. 
(2016) 
Salmonella, 
Netherlands in 
2012/2013 
Real       
€ 1.9 
million 
Shwiff et al. (2007) Rabies, California in 
1998-2002 
Real       
$3.7 
thousand 
per case 
Sartore et al. (2017) 
Rabies, Italy in 
2009/2016 Real      €4.7 million  
Siebert (2001) PD, California in 1999 Real $37.9 
million 
      
Tumber et al. (2014) 
PD, California in 
1999-2010 Real 
$104.4 
million       
Sardaro et al. (2015) PD, Italy (Puglia) in 
2013 
Real 
€104 per 
tree 
(medium 
firm) 
      
CBO (2005) 
Influenza Pandemic, 
US Simulated  -1.5%      
James & Sargent 
(2006) 
Influenza Pandemic, 
CAN 
Simulated  -0.4%      
McKibbin & 
Sidorenko (2006) 
Influenza Pandemic, 
World Simulated  -1.5%      
Kennedy et al. 
(2006) 
Influenza Pandemic, 
AUS Simulated  -9.3%      
Jonung & Röger 
(2006) 
Influenza Pandemic, 
EU 
Simulated  -1.6%      
Morgan and Prakash 
(2006) AI, EU Simulated    Price: +10%    
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Djunaidi & Djunaidi 
(2007) AI, US Simulated    Price: +10%    
Halasa et al. (2016a) ASF, Denmark Simulated €12 million   €350 million    
Garner et al. (2001) CSF, AUS Simulated 
€15-25 
million   $35 million    
Scottish Government 
(2008) BTV, Scotland Simulated £30 million   £70 million    
Tozer et al. (2015) FMD, CAN Simulated   
$26.4 
billion in 
30 years 
    
Paarlberg et al. 
(2002) FMD, US Simulated $14 billion       
Brown & Spreen 
(2000) 
Citrus Tristeza Virus, 
US Simulated 
Production 
reduction: 
30% 
  
Price increase: 
80%-90%    
Soliman et al. (2012) 
Pine Wood 
Nematode, EU Simulated €22 billion  
€218 
million in 
2030 
    
  
 Discussion 
Comparison of estimates per typology of costs turns out to be a complex task due to the 
fact that numerous diseases have been considered and different countries have been 
involved in the analysis. Hence, the discussion will be limited to those studies for which it 
exists a term of comparison.  
Direct economic impacts of 2006 BTV outbreak seem to have been consistently estimated 
by Velthius et al. (2015) and Gethmann et al. (2015) for Netherlands and Germany, 
respectively. As a matter of fact, costs are around 130€ million in the first case and 200€ 
million in the second case with the difference accounting for the spread of the disease. 
Lower estimates, i.e. £30 million, are reported for a simulated outbreak in Scotland by 
the Scottish Government (2008) report. For what concerns the spread of Pierce’s disease 
in California in 1999, Siebert (2001) indicates a total loss of $37.9 million while Tumber 
et al. (2014) estimates are about $104.4 million. The higher figure provided by the latter 
is due to the fact that the authors consider the costs of vine losses, industry 
assessments, compliance costs, and expenditures by government entities while Siebert 
(2001) only accounts for replanting entire vineyards and vineyard management.  
For what concerns GDP impact of the 2001 FMD outbreak in the UK, both Blake et al. 
(2014) and the Royal Society of Edinburgh (2002) report a reduction in GDP in the range 
of £2.1-£2.6 billion. Consistent estimates of GDP decrease are provided by those studies 
simulating an influenza pandemic. CBO (2005) for the US, James & Sargent (2006) for 
Canada, Jonung & Röger (2006) for EU and McKibbin & Sidorenko (2006) for the world 
argue that the drop in GDP may vary between 0.5% and 1.5%. Higher values are 
reported by Kennedy et al. (2006) for a possible pandemic in Australia.  
By looking at those studies evaluating the impact of diseases outbreaks on international 
markets, both Morgan and Prakash (2006) and Djunaidi & Djunaidi (2007) estimate an 
increase in poultry price of about 10% for EU and US, respectively. In general, the only 
study that seems not to be in line with all the others is the paper by Siettou (2016) who 
finds no association between poultry consumption and AI occurrence both within the UK 
territory and elsewhere in the world. The author himself suggests that the figures may in 
part be due to the fact that the studied outbreak was very small in magnitude and rapidly 
confined. Therefore, the result should be further tested, and outcomes of the paper must 
be taken with caution.  
For what concerns tourism expenditures, Thompson et al. (2002) and Blake et al. (2014) 
estimates a reduction of about £2.7-£3.2 billion and £6.7-£8.8 billion, respectively. The 
study of Thompson et al. (2002) has been subjected to serious data limitations; 
therefore, the analysis draws heavily on attitudinal data and a series of assumptions. On 
the other hand, Blake et al. (2014) adopt a Computable General Equilibrium model to 
estimate the effect on tourism. The reduction in international tourism receipts by region 
is calculated in the model by multiplying the international tourism receipts in each region 
for the “without-FMD” case by the percentage change in international receipts attributed 
to FMD in the UK as a whole. 
Finally, health costs of a Salmonella outbreak are similar for Ailes et al. (2013) and for 
Suijkerbuijk et al. (2016). The former estimates a cost of $2.6 million for the City of 
Alamosa, Colorado while the latter argue that health costs of the 2012/2013 Salmonella 
outbreak in the Netherlands is about €1.9 million.  
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 Additional materials 
Search Strategy for Scopus (Keywords) 
Cost analysis; Cost evaluation; Cost study; Cost of non-action; Indirect costs; Direct 
costs; Trade losses; Trade costs; Price; Farm productivity; Exports; Revenue farmers; 
Income farmers; Market losses; Economic Impact; Impact evaluation; Impact 
assessment. 
AND 
Outbreak; Crisis; Eradication; Zoonoses; Emergency measures; Pests; Prevention; Outer 
rest regions; Food crises; Veterinary crises; Phytosanitary crises; Rinderpest cattle 
plague; Sheep and goat plague; Swine vesicular disease; Bluetongue; Teschen disease; 
Sheep pox or goat pox; Rift Valley fever; Lumpy skin disease; African horse sickness; 
Vesicular stomatitis; Venezuelan equine viral encephalomyelitis; Haemorrhagic disease of 
deer; Classical swine fever; Rabies; Transmissible Spongiform Encephalopathies; African 
swine fever; Contagious bovine pleuropneumonia; Avian influenza; Newcastle disease; 
Foot-and-mouth disease; Epizootic haematopoietic necrosis in fish (EHN); Epizootic 
ulcerative syndrome in fish (EUS); Infection with Bonamia exitiosa; Infection with 
Perkinsus marinus; Infection with Microcytos mackini; Taura syndrome in crustaceans; 
Yellowhead disease in crustaceans; Plant pests; Bursaphelenchus xylophilus; 
Anoplophora chinensis; Anoplophora glabripennis; Pomacea insularum; Pomacea 
maculata; Ralstonia Solanacearum; Xylella fastidiosa; Citrus Tristeza virus; giant 
applesnail; island applesnail; applesnail; pine wood nematode; pine wilt nematode; pine 
wilt; citrus long-horned beetle; long-horned beetle; Asian long-horned beetle; starry sky; 
sky beetle; olive quick decline syndrome; phoney peach disease; bacterial leaf scorch; 
oleander leaf scorch; Pierce's disease; citrus variegated chlorosis disease. 
  
 Flow diagram of excluded and included studies 
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 Annex 2. Example of dataset 
 
 
 
Description of the variables in the dataset: 
— countrycode  Country identifier  
— regcode  NUTS2 region identifier 
— diseasecode disease identifier 
— Treated  Receives EU funding 
— status  Disease Status (1=not free, 0=free)   
— EUFund  EU Funding received 
— GDP   National GDP (in 2010 mln EUR)  
— NLiveStock  Livestock units in farms   
— NFarm   Number of farms  
— Farm_area  Farm Area (in hectares) 
— Agr_area   Agricultural Area (in hectares) 
— NOutBreaks Number of Secondary Outbreaks  
 
 
   
   
GETTING IN TOUCH WITH THE EU 
In person 
All over the European Union there are hundreds of Europe Direct information centres. You can find the 
address of the centre nearest you at: https://europa.eu/european-union/contact_en 
On the phone or by email 
Europe Direct is a service that answers your questions about the European Union. You can contact this 
service: 
- by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls), 
- at the following standard number: +32 22999696, or 
- by electronic mail via: https://europa.eu/european-union/contact_en 
FINDING INFORMATION ABOUT THE EU 
Online 
Information about the European Union in all the official languages of the EU is available on the Europa 
website at: https://europa.eu/european-union/index_en 
EU publications 
You can download or order free and priced EU publications from EU Bookshop at: 
https://publications.europa.eu/en/publications. Multiple copies of free publications may be obtained by 
contacting Europe Direct or your local information centre (see https://europa.eu/european-
union/contact_en). 
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